<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">05098</article-id><article-id pub-id-type="doi">10.7554/eLife.05098</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology and Stem Cells</subject></subj-group></article-categories><title-group><article-title>In vitro generation of human pluripotent stem cell derived lung organoids</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-20131"><name><surname>Dye</surname><given-names>Briana R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29331"><name><surname>Hill</surname><given-names>David R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataro1"/></contrib><contrib contrib-type="author" id="author-20132"><name><surname>Ferguson</surname><given-names>Michael AH</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20133"><name><surname>Tsai</surname><given-names>Yu-Hwai</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29332"><name><surname>Nagy</surname><given-names>Melinda S</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20138"><name><surname>Dyal</surname><given-names>Rachel</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-5637"><name><surname>Wells</surname><given-names>James M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29333"><name><surname>Mayhew</surname><given-names>Christopher N</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29334"><name><surname>Nattiv</surname><given-names>Roy</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20080"><name><surname>Klein</surname><given-names>Ophir D</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20134"><name><surname>White</surname><given-names>Eric S</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20135"><name><surname>Deutsch</surname><given-names>Gail H</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-19741"><name><surname>Spence</surname><given-names>Jason R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataro1"/><xref ref-type="other" rid="dataro2"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Cell and Developmental Biology</institution>, <institution>University of Michigan Medical School</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Internal Medicine</institution>, <institution>University of Michigan Medical School</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Division of Developmental Biology</institution>, <institution>Cincinnati Children's Hospital Medical Center</institution>, <addr-line><named-content content-type="city">Cincinnati</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Division of Endocrinology</institution>, <institution>Cincinnati Children's Hospital Medical Center</institution>, <addr-line><named-content content-type="city">Cincinnati</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Institute for Human Genetics, Department of Pediatrics</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Program in Craniofacial and Mesenchymal Biology</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><label>7</label><institution content-type="dept">Center for Craniofacial Anomalies</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><label>8</label><institution content-type="dept">Department of Laboratories</institution>, <institution>Seattle Children's Hospital and University of Washington</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><label>9</label><institution content-type="dept">Center for Organogenesis</institution>, <institution>University of Michigan Medical School</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1024"><name><surname>Rossant</surname><given-names>Janet</given-names></name><role>Reviewing editor</role><aff><institution>University of Toronto</institution>, <country>Canada</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>spencejr@umich.edu</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>03</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>4</volume><elocation-id>e05098</elocation-id><history><date date-type="received"><day>09</day><month>10</month><year>2014</year></date><date date-type="accepted"><day>24</day><month>02</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, Dye et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Dye et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-05098-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.05098.001</object-id><p>Recent breakthroughs in 3-dimensional (3D) organoid cultures for many organ systems have led to new physiologically complex in vitro models to study human development and disease. Here, we report the step-wise differentiation of human pluripotent stem cells (hPSCs) (embryonic and induced) into lung organoids. By manipulating developmental signaling pathways hPSCs generate ventral-anterior foregut spheroids, which are then expanded into human lung organoids (HLOs). HLOs consist of epithelial and mesenchymal compartments of the lung, organized with structural features similar to the native lung. HLOs possess upper airway-like epithelium with basal cells and immature ciliated cells surrounded by smooth muscle and myofibroblasts as well as an alveolar-like domain with appropriate cell types. Using RNA-sequencing, we show that HLOs are remarkably similar to human fetal lung based on global transcriptional profiles, suggesting that HLOs are an excellent model to study human lung development, maturation and disease.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.001">http://dx.doi.org/10.7554/eLife.05098.001</ext-link></p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.05098.002</object-id><title>eLife digest</title><p>Cell behavior has traditionally been studied in the lab in two-dimensional situations, where cells are grown in thin layers on cell-culture dishes. However, most cells in the body exist in a three-dimensional environment as part of complex tissues and organs, and so researchers have been attempting to re-create these environments in the lab. To date, several such ‘organoids’ have been successfully generated, including models of the human intestine, stomach, brain and liver. These organoids can mimic the responses of real tissues and can be used to investigate how organs form, change with disease, and how they might respond to potential therapies.</p><p>Here, Dye et al. developed a new three-dimensional model of the human lung by coaxing human stem cells to become specific types of cells that then formed complex tissues in a petri dish. To make these lung organoids, Dye et al. manipulated several of the signaling pathways that control the formation of organs during the development of animal embryos. First, the stem cells were instructed to form a type of tissue called endoderm, which is found in early embryos and gives rise to the lung, liver and other several other internal organs.</p><p>Then, Dye et al. activated two important developmental pathways that are known to make endoderm form three-dimensional intestinal tissue. However, by inhibiting two other key developmental pathways at the same time, the endoderm became tissue that resembles the early lung found in embryos instead.</p><p>This early lung-like tissue formed three-dimensional spherical structures as it developed. The next challenge was to make these structures develop into lung tissue. Dye et al. worked out a method to do this, which involved exposing the cells to additional proteins that are involved in lung development. The resulting lung organoids survived in laboratory cultures for over 100 days and developed into well-organized structures that contain many of the types of cells found in the lung.</p><p>Further analysis revealed the gene activity in the lung organoids resembles that of the lung of a developing human fetus, suggesting that lung organoids grown in the dish are not fully mature. Dye et al.'s findings provide a new approach for creating human lung organoids in culture that may open up new avenues for investigating lung development and diseases.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.002">http://dx.doi.org/10.7554/eLife.05098.002</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author keywords</title><kwd>pluripotent stem cell</kwd><kwd>organoid</kwd><kwd>endoderm</kwd><kwd>lung</kwd><kwd>foregut</kwd><kwd>spheroid</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute (NHBLI)</institution></institution-wrap></funding-source><award-id>R21HL115372</award-id><principal-award-recipient><name><surname>Spence</surname><given-names>Jason R</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000912</institution-id><institution>March of Dimes Foundation</institution></institution-wrap> </funding-source><award-id>Basil O'Connor starter scholar award</award-id><principal-award-recipient><name><surname>Spence</surname><given-names>Jason R</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</institution></institution-wrap></funding-source><award-id>K01DK091415</award-id><principal-award-recipient><name><surname>Spence</surname><given-names>Jason R</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute (NHBLI)</institution></institution-wrap></funding-source><award-id>R01HL119215</award-id><principal-award-recipient><name><surname>Spence</surname><given-names>Jason R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Directed differentiation of stem cells can generate ventral-anterior foregut spheroids that can expand into three-dimensional lung organoids with striking structural, cellular and molecular similarities to the human fetal lung.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Several reports have demonstrated that directed differentiation of human pluripotent stem cells (hPSCs), which include embryonic (hESCs) and induced (iPSCs) stem cells, is one of the most efficient approaches to achieving differentiation of a cell or tissue of interest (<xref ref-type="bibr" rid="bib16">D'Amour et al., 2005</xref>; <xref ref-type="bibr" rid="bib37">Kroon et al., 2008</xref>; <xref ref-type="bibr" rid="bib70">Si-Tayeb et al., 2009</xref>; <xref ref-type="bibr" rid="bib72">Spence et al., 2011</xref>; <xref ref-type="bibr" rid="bib87">Wong et al., 2012</xref>). Using this approach, differentiation of hPSCs into lung lineages has been achieved using diverse methodology with varying degrees of success (<xref ref-type="bibr" rid="bib34">Kadzik and Morrisey, 2012</xref>; <xref ref-type="bibr" rid="bib44">Longmire et al., 2012</xref>; <xref ref-type="bibr" rid="bib55">Mou et al., 2012</xref>; <xref ref-type="bibr" rid="bib87">Wong et al., 2012</xref>; <xref ref-type="bibr" rid="bib26">Ghaedi et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Huang et al., 2013</xref>; <xref ref-type="bibr" rid="bib24">Firth et al., 2014</xref>).</p><p>Thus far, the majority of efforts to differentiate lung lineages from hPSCs have focused on using 2-dimensional (2D) monolayer cultures. Several recent advances in generating 3-dimensional (3D) organ-like tissues, called ‘organoids’, have been reported (<xref ref-type="bibr" rid="bib49">Meyer et al., 2011</xref>; <xref ref-type="bibr" rid="bib72">Spence et al., 2011</xref>; <xref ref-type="bibr" rid="bib57">Nakano et al., 2012</xref>; <xref ref-type="bibr" rid="bib76">Takebe et al., 2013</xref>; <xref ref-type="bibr" rid="bib39">Lancaster et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">McCracken et al., 2014</xref>). Such 3D models offer several advantages; they often possess structural organization similar to the native organ, cell types from multiple germ layers (for example, mesoderm and endoderm (<xref ref-type="bibr" rid="bib72">Spence et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">McCracken et al., 2014</xref>; <xref ref-type="bibr" rid="bib85">Wells and Spence, 2014</xref>), and multiple cellular lineages, making them a physiologically complex model to study developmental processes, tissue homeostasis and pathological conditions in vitro.</p><p>Previous work has demonstrated that activation of FGF and WNT signaling synergistically drives CDX2+ intestinal lineage commitment in hPSC-derived endoderm and also drives ‘morphogenesis in a dish’, where the 2D tissues self-organize into 3D spheroids comprised of mesenchymal and polarized epithelial layers that detach from the adherent cell layer (<xref ref-type="bibr" rid="bib72">Spence et al., 2011</xref>). It has also been demonstrated that inhibition of BMP and TGFβ signaling is able to drive tissue into a SOX2+ foregut lineage (<xref ref-type="bibr" rid="bib27">Green et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">McCracken et al., 2014</xref>). Building on these previous studies, we show that simultaneous stimulation of WNT and FGF signaling while inhibiting BMP/TGFβ signaling pathways in hPSC-derived endoderm cultures prevents intestinal lineage commitment, and instead, favors a SOX2+ anterior foregut fate while also robustly generating SOX2+ anterior foregut 3D spheroid structures.</p><p>In order to further restrict foregut spheroids to the lung lineage, the current study focused on manipulating FGF and HH signaling. In the mouse, high levels of Fgf signaling have been shown to induce Shh expression in the lung endoderm (<xref ref-type="bibr" rid="bib29">Hebrok et al., 1998</xref>; <xref ref-type="bibr" rid="bib53">Morrisey and Hogan, 2010</xref>; <xref ref-type="bibr" rid="bib63">Rankin and Zorn, 2014</xref>) which is accompanied by induction of the Nkx2.1+ lung progenitor field (<xref ref-type="bibr" rid="bib29">Hebrok et al., 1998</xref>; <xref ref-type="bibr" rid="bib69">Serls, 2004</xref>). Shh then signals from the endoderm to the mesoderm, and mutations in <italic>Shh, Gli2</italic> or <italic>Gli3</italic> lead to perturbed lung development, with <italic>Gli2/Gli3</italic> double knockout mice showing lung agenesis (<xref ref-type="bibr" rid="bib4">Bellusci et al., 1997a</xref>; <xref ref-type="bibr" rid="bib54">Motoyama et al., 1998</xref>; <xref ref-type="bibr" rid="bib42">Li et al., 2004</xref>). Our results demonstrate that FGF2 induces NKX2.1, PAX8, and SHH in human foregut endoderm cultures. By using pharmacological inhibitors of FGF and HH signaling we demonstrate that SHH is required for NKX2.1 expression downstream of FGF2, and that FGF2 also induces PAX8 independently of HH signaling. These observations suggest a paradigm where FGF<sup>Lo</sup>/HH<sup>Hi</sup> conditions preferentially induce PAX8<sup>Lo</sup>/NKX2.1<sup>Hi</sup> lung progenitors and FGF<sup>Hi</sup>/HH<sup>Lo</sup> conditions favor a PAX8<sup>Hi</sup>/NKX2.1<sup>Lo</sup> fate. Given that Pax8 is required for thyroid development, we focused on defining the most robust conditions to induce NKX2.1 while minimizing PAX8 expression (<xref ref-type="bibr" rid="bib36">Kimura et al., 1996</xref>; <xref ref-type="bibr" rid="bib46">Mansouri et al., 1998</xref>; <xref ref-type="bibr" rid="bib89">Yuan et al., 2000</xref>; <xref ref-type="bibr" rid="bib79">Vilain et al., 2001</xref>; <xref ref-type="bibr" rid="bib42">Li et al., 2004</xref>; <xref ref-type="bibr" rid="bib38">Kusakabe et al., 2006</xref>; <xref ref-type="bibr" rid="bib10">Carré et al., 2009</xref>; <xref ref-type="bibr" rid="bib58">Narumi et al., 2012</xref>). By applying HH<sup>Hi</sup> conditions during generation of foregut spheroids we were able to enhance NKX2.1 expression in foregut spheroids and subsequently expand spheroids in media containing FGF10, allowing them to grow into organoids. Organoids persisted in culture for over 100 days and developed well-organized proximal-like airway epithelial structures that included many cell types found in the proximal lung epithelium, including basal and ciliated cells along with rare club cells. Moreover, proximal airway structures were often surrounded by smooth muscle actin (SMA) positive mesenchymal tissue. Organoids also possessed distal-like epithelial cells that co-expressed progenitor markers, SFTPC/SOX9 and HOPX/SOX9, consistent with early bipotent alveolar progenitor cells seen in mice (<xref ref-type="bibr" rid="bib20">Desai et al., 2014</xref>; <xref ref-type="bibr" rid="bib78">Treutlein et al., 2014</xref>). To support the idea that organoids may be more similar to a developing lung with abundant progenitor cells, we used RNA-sequencing to compare the global transcriptional profile of organoids to the human fetal and adult lung, undifferentiated hESCs and definitive endoderm. Principal component analysis, hierarchical clustering and Spearman's correlation all show that organoids have striking similarity to the human fetal lung.</p><p>Taken together, our data demonstrates an efficient and robust in vitro system to generate complex, 3D human lung organoids that are immature/fetal in nature. We anticipate that this model will serve as an unparalleled model for the study of human lung development, maturation and disease.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Differentiation of hPSCs into anterior foregut spheroids</title><p>We and others have reported efficient induction of human endoderm using ActivinA (<xref ref-type="bibr" rid="bib16">D'Amour et al., 2005</xref>; <xref ref-type="bibr" rid="bib90">Zhang et al., 2010</xref>; <xref ref-type="bibr" rid="bib72">Spence et al., 2011</xref>), and a further lineage restriction into SOX2+ anterior foregut endoderm using inhibition of BMP and TGFβ signaling (<xref ref-type="bibr" rid="bib27">Green et al., 2011</xref>; <xref ref-type="bibr" rid="bib43">Loh et al., 2014</xref>). We have recently demonstrated that inhibition of BMP signaling during intestinal lineage induction with WNT and FGF ligands is sufficient to inhibit intestinal CDX2 and induce SOX2+ posterior foregut spheroids capable of giving rise to human gastric (antral) organoids (<xref ref-type="bibr" rid="bib48">McCracken et al., 2014</xref>). Given that the lung is derived from the anterior foregut, we sought to define conditions to generate ventral anterior foregut spheroids. To do this, we tested if dual inhibition of BMP and TGFβ was able to anteriorize cultures, as previously described (<xref ref-type="bibr" rid="bib27">Green et al., 2011</xref>). We treated hESCs with ActivinA (100 ng/ml) for 4 days to induce endoderm, followed by 4 days of Noggin (NOG, 200 ng/ml) and the small molecule TGFβ inhibitor, SB431542 (SB, 10 µM). We confirmed that these conditions were able to induce robust mRNA and protein expression of SOX2, which co-expressed the endodermal marker FOXA2, while repressing the intestinal lineage marker CDX2 (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). QRT-PCR analysis also showed that compared to controls (in which endoderm was induced but was not exposed to NOG/SB), exposure to NOG/SB robustly induced ventral anterior foregut genes <italic>NKX2.1</italic> and <italic>PAX8</italic>, while the posterior foregut transcript, <italic>PDX1</italic> was reduced. <italic>HHEX</italic>, which is expressed in the developing liver, biliary system and thyroid, but is absent from the lung primordium, remained unchanged (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Given that NKX2.1 is expressed in the lung and thyroid primordium, and PAX8 is expressed in the thyroid primordium, these results suggest that 4 day ActivinA treatment followed by a 4 day NOG/SB treatment biases the cultures towards ventral-anterior foregut lineages.<fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.05098.003</object-id><label>Figure 1.</label><caption><title>Generation of three-dimensional ventral anterior foregut spheroids from endoderm monolayers.</title><p>(<bold>A</bold>) hESCs were differentiated into foregut endoderm by treating cells with 4 days of Activin A (ACTA) followed by 4 days of NOG+SB. (<bold>B</bold>) Foregut endoderm (NOG+SB) had high expression of the foregut marker <italic>SOX2</italic> while the hindgut marker <italic>CDX2</italic> was significantly reduced compared to untreated endoderm controls (End). NOG+SB monolayers had high expression of ventral anterior foregut genes <italic>NKX2.1</italic> and <italic>PAX8</italic> while the posterior foregut marker <italic>PDX1</italic> was reduced. The foregut marker <italic>HHEX</italic> is expressed in the developing liver, biliary system, and thyroid and remained unchanged. (<bold>C</bold>) The majority of cells in NOG+SB treated cultures were SOX2 positive (green) compared to the control, in which only scattered clusters of cells were SOX2 positive. The scale bar represents 200 µm. (<bold>D</bold>) hESCs were differentiated into foregut spheroids by treating cells with 4 days of ACTA and then additional 4–6 days of NOG+SB+FGF4+Ch. Representative images of a spheroid in a matrigel droplet are shown as a whole mount image. Scale bar represents 100 µm. (<bold>E</bold>) Foregut spheroids (NOG+SB+FGF4+Ch) had high expression of the foregut marker <italic>SOX2</italic> while the hindgut marker <italic>CDX2</italic> was significantly reduced compared to untreated endoderm control (End) (top panel). Spheroids had high expression of anterior foregut genes <italic>NKX2.1</italic> and <italic>PAX8</italic> while the posterior foregut marker <italic>PDX1</italic> was reduced and HHEX was unchanged (bottom panel). *p &lt; 0.05, error bars represent SEM. (<bold>F</bold>) The majority of cells in foregut spheroids are FOXA2+ (green, left panel) and SOX2+ (white, right panel) and ECAD+ (red, right panel). Scale bar represent 50 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.003">http://dx.doi.org/10.7554/eLife.05098.003</ext-link></p></caption><graphic xlink:href="elife-05098-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Monolayer cultures express lung specific markers.</title><p>Immunohistochemistry for markers expressed in endoderm, ventral foregut or lung epithelium were assessed (SOX2, FOXA2, NKX2.1, SOX9) in endoderm controls, foregut controls or foregut cultures treated with SAG or SAG+SU. (<bold>A</bold>) All conditions express endoderm marker FOXA2 (red), but the foregut (NOG+SB) control, SAG and SAG+SU treated cultures have co-expression of FOXA2 (red) and SOX2 (green) in the majority of cells. (<bold>B</bold>) All conditions expressed endoderm marker FOXA2 (red), but only foregut endoderm treated with SAG and SAG+SU have robust NKX2.1+ cells (green) that also express FOXA2 (red). (<bold>A</bold>–<bold>B</bold>) Scale bars represent 200 µm and apply to all images. (<bold>C</bold>) Only foregut endoderm treated with SAG and SAG+SU have robust NKX2.1+ cells (green) with the majority of cell co-expressing with lung epithelial marker SOX9 (red). Scale bar represents 100 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.004">http://dx.doi.org/10.7554/eLife.05098.004</ext-link></p></caption><graphic xlink:href="elife-05098-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.005</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Foregut spheroids co-express endoderm and lung specific markers.</title><p>(<bold>A</bold>) NOG/SB/FGF4/Ch spheroids have weak NKX2.1 (green) expression which co-expresses with endoderm marker FOXA2 (red). (<bold>B</bold>) The majority of cells in the spheroid express SOX2 (green) and co-stain with FOXA2 (red). Scale bars represent 50 µM.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.005">http://dx.doi.org/10.7554/eLife.05098.005</ext-link></p></caption><graphic xlink:href="elife-05098-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.006</object-id><label>Figure 1—figure supplement 3.</label><caption><title>Foregut spheroids consist of both epithelial and mesenchymal cells.</title><p>NOG/SB/FGF4/Ch spheroids have a minor population of Vimentin (VIM, white) positive mesenchymal cells, while the majority of cells are epithelial and express ECAD (red). Scale bar represents 50 µM.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.006">http://dx.doi.org/10.7554/eLife.05098.006</ext-link></p></caption><graphic xlink:href="elife-05098-fig1-figsupp3-v1.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.007</object-id><label>Figure 1—figure supplement 4.</label><caption><title>NOG+SB+FGF4+Ch spheroids do not express neural markers.</title><p>hESCs were differentiated into endoderm by treating with 4 days of ActivinA (ACTA) and spheroids were generated with an additional 4 days of NOG+SB+FGF4+Ch. Neural cultures were not treated with ACTA, but were treated with NOG+SB for 8 days. Compared to foregut spheroids (NOG+SB+FGF4+Ch), NOG+SB neural cultures had a significant increase in neural markers <italic>NESTIN</italic>, <italic>SOX1</italic>, and <italic>PAX6</italic> and significant decrease in <italic>FOXA2</italic>, which is highly expressed in endoderm. *p &lt; 0.05, error bars represent SEM.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.007">http://dx.doi.org/10.7554/eLife.05098.007</ext-link></p></caption><graphic xlink:href="elife-05098-fig1-figsupp4-v1.tif"/></fig></fig-group></p><p>Addition of FGF4 plus WNT3A (or Chir99021, a GSK3β inhibitor that enhances β-catenin dependent WNT signaling) promotes CDX2 intestinal lineage commitment and 3D spheroid formation in endoderm cultures (<xref ref-type="bibr" rid="bib72">Spence et al., 2011</xref>; <xref ref-type="bibr" rid="bib88">Xue et al., 2013</xref>; <xref ref-type="bibr" rid="bib14">Chen et al., 2014b</xref>). Based on our results in <xref ref-type="fig" rid="fig1">Figure 1B–C</xref>, we hypothesized that combining FGF, Chir99021, NOG and SB would result in the generation of SOX2+ ventral-anterior foregut spheroids. To test this, we generated endoderm (4 days ACTA) and added no growth factors (Endoderm controls) or NOG, SB, FGF4, and Chir99021 (NOG/SB/F/Ch) (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Addition of all four factors resulted in the generation of 3-dimensional SOX2+, CDX2− spheroids (<xref ref-type="fig" rid="fig1">Figure 1E,F</xref>). SOX2+ spheroids also expressed the endodermal protein FOXA2, and were epithelial, co-expressing E-Cadherin (ECAD) (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). In addition to SOX2, spheroids exhibited higher mRNA expression of anterior foregut lineage markers <italic>NKX2.1</italic> and <italic>PAX8</italic> compared to endoderm controls, suggesting that they are ventral-anterior foregut spheroids (<xref ref-type="fig" rid="fig1">Figure 1E</xref>), however, immunofluorescence revealed that levels of NKX2.1 protein were just above the detection threshold (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Spheroids also possess a minor population of cells that are mesodermal in origin staining positive for Vimentin protein (VIM) (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). Given that neural tissues also express NKX2.1, PAX8, SOX2, and FOXA2, and that neural induction protocols use dual BMP and TGFβ inhibition, we wanted to exclude the possibility that spheroids were neural in nature. To do this, we generated endoderm control cultures, foregut spheroids (ActivinA followed by NOG/SB/F/Ch), and induced neural tissue by adding NOG/SB to hESC cultures that were not treated with ActivinA (<xref ref-type="bibr" rid="bib11">Chambers et al., 2009</xref>). By examining induction of the neural markers <italic>NESTIN, SOX1,</italic> and <italic>PAX6</italic>, we confirmed that these transcripts were highly induced in dual NOG/SB neural cultures, but were low in ventral foregut spheroid cultures. In contrast, <italic>FOXA2</italic>, which is expressed in the foregut (<xref ref-type="bibr" rid="bib51">Monaghan et al., 1993</xref>; <xref ref-type="bibr" rid="bib3">Ang and Rossant, 1994</xref>; <xref ref-type="bibr" rid="bib16">D'Amour et al., 2005</xref>, <xref ref-type="bibr" rid="bib18">2006</xref>; <xref ref-type="bibr" rid="bib37">Kroon et al., 2008</xref>; <xref ref-type="bibr" rid="bib70">Si-Tayeb et al., 2009</xref>; <xref ref-type="bibr" rid="bib19">DeLaForest et al., 2011</xref>) and in some neural tissues (<xref ref-type="bibr" rid="bib70"/><xref ref-type="bibr" rid="bib74">Stott et al., 2013</xref>), had high expression in ventral foregut spheroids, but was significantly reduced in dual NOG/SB neural conditions (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). Taken together, these results strongly suggest spheroids are indeed foregut, and not of neural origin.</p></sec><sec id="s2-2"><title>Induction of anterior foregut endoderm into a lung lineage through modulation of FGF and HH signaling</title><p>Many signaling pathways are important for lung induction and development (reviewed in <xref ref-type="bibr" rid="bib50">Min et al., 1998</xref>; <xref ref-type="bibr" rid="bib83">Weaver et al., 2000</xref>; <xref ref-type="bibr" rid="bib53">Morrisey and Hogan, 2010</xref>; <xref ref-type="bibr" rid="bib63">Rankin and Zorn, 2014</xref>). High levels of Fgf signaling have been shown to induce Shh and Nkx2.1 expression in the foregut endoderm in mice (<xref ref-type="bibr" rid="bib29">Hebrok et al., 1998</xref>; <xref ref-type="bibr" rid="bib69">Serls, 2004</xref>); furthermore, Gli2/3 null mouse embryos fail to form lungs (<xref ref-type="bibr" rid="bib54">Motoyama et al., 1998</xref>) and Hh signaling is important for lung mesenchyme proliferation in vivo (<xref ref-type="bibr" rid="bib4">Bellusci et al., 1997a</xref>). These data confirm that Fgf and Hh signaling are critical for lung specification and ligands from both signaling pathways have been applied to hPSC derived lung lineages in 2D cultures (<xref ref-type="bibr" rid="bib87">Wong et al., 2012</xref>; <xref ref-type="bibr" rid="bib32">Huang et al., 2013</xref>). In our cultures we have reported that approximately 85–95% of cells are endoderm, but a portion of the remaining cells are mesodermal and this small mesodermal population is maintained in the spheroids and organoids (<xref ref-type="bibr" rid="bib72">Spence et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">McCracken et al., 2014</xref>) (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). Therefore, based on mouse and hPSC studies, we hypothesized that FGF and/or HH signaling would induce an NKX2.1+ lung lineage in anterior foregut endoderm. To test our hypothesis we initially focused on adherent endoderm monolayer cultures to optimize induction conditions. Cultures were treated for 4 days with ActivinA followed by an additional 4 days with NOG/SB (referred to as Foregut). Controls consisted of ActivinA treatment only followed by no additional growth factors (Endoderm controls), or ActivinA followed by NOG/SB, followed by no additional factors (Foregut controls). All experimental groups were compared to both endoderm and foregut controls (<xref ref-type="fig" rid="fig2">Figure 2</xref>). We first tested the ability of FGF2 to induce <italic>SHH</italic>, <italic>NKX2.1</italic> and <italic>PAX8</italic> by exposing foregut cultures to low and high concentrations of FGF2 (50, 500 ng/ml) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We observed a robust concentration dependent increase in <italic>SHH</italic> and <italic>PAX8</italic> mRNA expression compared to foregut or endoderm controls, and a modest increase of <italic>NKX2.1</italic> expression at the highest dose of FGF2 (500 ng/ml) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We also observed that dual NOG/SB inhibition in endoderm cultures induced robust <italic>NKX2.1</italic> and <italic>PAX8</italic> expression without adding FGF2 (<xref ref-type="fig" rid="fig1 fig2">Figures 1B, 2A</xref>). Thus, we wanted to determine if <italic>NKX2.1</italic> expression in foregut cultures was due to endogenous FGF and/or HH signaling. To test this, we inhibited the FGF or HH pathway with small molecules SU5402 (SU, 10 µm) and Sant-2 (10 µm) respectively (<xref ref-type="fig" rid="fig2">Figure 2B–C</xref>). Treating foregut cultures with the FGF inhibitor SU caused a significant, robust reduction in <italic>PAX8</italic> and a modest reduction in <italic>SHH</italic>, while <italic>NKX2.1</italic> expression was unchanged compared to foregut controls (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Conversely, inhibition of HH signaling caused a significant reduction in <italic>NKX2.1</italic> expression, but not <italic>PAX8</italic> compared to untreated foregut<italic>.</italic> When FGF2 was added to the cultures, we observed a modest increase in <italic>NKX2.1</italic> expression, and when FGF was added along with Sant-2, <italic>NKX2.1</italic> expression was significantly reduced (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Together our results suggest a hierarchy where FGF is upstream of SHH and PAX8, and where SHH is upstream of NKX2.1. To test if HH signaling was able to induce NKX2.1 in foregut cultures, we added the Smoothened agonist, SAG (1 µM) to foregut cultures. The addition of SAG induced a 6.5-fold increase of <italic>NKX2.1</italic> expression above foregut controls (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). However, SAG alone did not reduce <italic>PAX8</italic> expression.<fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.05098.008</object-id><label>Figure 2.</label><caption><title>Induction of NKX2.1 in anterior foregut endoderm by modulating FGF and HH signaling.</title><p>(<bold>A</bold>) hESCs were differentiated into endoderm (End) or anterior foregut with NOG+SB (For). Anterior foregut was treated with low (50 ng/ml) and high (500 ng/ml) concentrations of FGF2. FGF2 caused a dose-dependent increase in <italic>SHH</italic> and <italic>PAX8</italic> expression with a modest increase in <italic>NKX2.1</italic> expression compared to untreated endoderm controls. Note that <italic>NKX2.1</italic> expression is increased by NOG+SB exposure alone (no FGF2). (<bold>B</bold>) Addition of the FGF inhibitor SU5402 (SU) to NOG+SB foregut cultures (For) caused a significant reduction of <italic>SHH</italic> and <italic>PAX8</italic> expression, but <italic>NKX2.1, GLI1</italic>, and <italic>PTCH1</italic> were not significantly different compared to the foregut controls, in which no growth factors were added after SB+NOG. (<bold>C</bold>) Addition of the HH inhibitor Sant-2 caused a significant reduction in <italic>NKX2.1</italic> compared to foregut control. Similarly when FGF2 (500 ng/ml) and Sant-2 were added simultaneously, the modest <italic>NKX2.1</italic> induction caused by FGF2 was significantly reduced whereas <italic>PAX8</italic> expression remained unchanged. (<bold>D</bold>) Foregut endoderm treated with SAG or SAG+SU for 8 days had a 6.5-fold and 21-fold increase of <italic>NKX2.1</italic> expression, respectively, compared to untreated foregut controls. <italic>PAX8</italic> expression was unchanged in the SAG treated cultures whereas SAG+SU treated cultures demonstrated a 41-fold decrease in <italic>PAX8</italic> expression. End = endoderm; For = foregut in all panels. *p &lt; 0.05, error bars represent SEM.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.008">http://dx.doi.org/10.7554/eLife.05098.008</ext-link></p></caption><graphic xlink:href="elife-05098-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.009</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Robust induction of NKX2.1 in foregut endoderm with HH stimulation and FGF inhibition.</title><p>(<bold>A</bold>) Immunohistochemistry of NKX2.1 and PAX8 in endoderm controls, foregut controls or foregut cultures treated with SAG or SAG+SU. Treatment of foregut cultures with SAG or SAG+SU resulted in more NKX2.1+ cells compared to endoderm and foregut controls. Scale bars represent 200 µm and apply to all images. (<bold>B</bold>) Quantification showed that 20% ± 4% of cells in foregut controls were NKX2.1+, whereas 72% ± 3% cells were positive in SAG+SU treated cultures (*p &lt; 0.05). All error bars represent SEM.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.009">http://dx.doi.org/10.7554/eLife.05098.009</ext-link></p></caption><graphic xlink:href="elife-05098-fig2-figsupp1-v1.tif"/></fig></fig-group></p><p>Based on these results, we further hypothesized that enhancing HH signaling would result in increased <italic>NKX2.1</italic> expression downstream of FGF, and that simultaneous inhibition of FGF signaling would reduce PAX8 expression; therefore, we inhibited endogenous FGF signaling with SU while activating HH with SAG (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). This combination caused an additional increase in <italic>NKX2.1</italic> expression (21-fold vs 6.5-fold with SAG only, when compared to foregut) and a concomitant decrease in <italic>PAX8</italic> mRNA (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Importantly, immunofluorescence was correlated with QRT-PCR data showing an increased number of NKX2.1+ cells with the addition of SAG only. SAG+SU treated cultures showed a further increase in the number of NKX2.1 expressing cells, with ∼77% of all cells expressing NKX2.1 compared to ∼20% in foregut controls, and almost no PAX8 expressing cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). SAG and SAG+SU treated cells also co-expressed FOXA2 and SOX2 confirming their endodermal origin (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p></sec><sec id="s2-3"><title>HH-induced foregut spheroids give rise to human lung organoids (HLOs)</title><p>Based on the observations that stimulating HH and inhibiting FGF signaling strongly enhances NKX2.1 expression while reducing PAX8 expression (<xref ref-type="fig" rid="fig2">Figure 2</xref>), we tested multiple conditions of HH activation and FGF inhibition to induce NKX2.1<sup>HI</sup>/PAX8<sup>LO</sup> foregut spheroids (NOG/SB/F/Ch) (Summarized in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Consistent with the important roles of FGF signaling in lung growth and branching morphogenesis (<xref ref-type="bibr" rid="bib29">Hebrok et al., 1998</xref>; <xref ref-type="bibr" rid="bib50">Min et al., 1998</xref>; <xref ref-type="bibr" rid="bib83">Weaver et al., 2000</xref>; <xref ref-type="bibr" rid="bib1">Abler et al., 2009</xref>; <xref ref-type="bibr" rid="bib53">Morrisey and Hogan, 2010</xref>; <xref ref-type="bibr" rid="bib63">Rankin and Zorn, 2014</xref>), we found that conditions where FGF inhibition was used led to a reduction of epithelial tissue relative to mesenchymal tissue, which could be due to a loss of epithelium or an overgrowth of mesenchyme; this suggests that endogenous FGF signaling is necessary to maintain the epithelial tissue in 3D cultures (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Therefore, we also tested several conditions that stimulated HH signaling using SAG only, without FGF inhibition. We found that the most efficient method to enhance NKX2.1 expression was by adding SAG during the foregut spheroid phase (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Comparing foregut spheroids (NOG/SB/F/Ch) with those treated with SAG (NOG/SB/F/Ch/SAG), we observed a substantial decrease in <italic>SOX2</italic> expression compared to NOG/SB/F/Ch spheroids and a significant increase in <italic>NKX2.1</italic> mRNA. Additionally, nuclear NKX2.1 protein expression was found in ECAD+ epithelium which co-expressed endoderm epithelial markers FOXA2 and SOX2 (<xref ref-type="fig" rid="fig3">Figure 3B,C</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). Interestingly, during lung specification in mice, the gut tube initially expresses Sox2 throughout the endoderm, but Sox2 is down-regulated in the lung field during lung specification and Nkx2.1 induction (<xref ref-type="bibr" rid="bib29">Hebrok et al., 1998</xref>; <xref ref-type="bibr" rid="bib69">Serls, 2004</xref>; <xref ref-type="bibr" rid="bib21">Domyan et al., 2011</xref>). Thus, concomitant down-regulation of <italic>SOX2</italic> and increased <italic>NKX2.1</italic> observed in SAG treated foregut spheroids is consistent with early transcriptional changes that occur during lung specification in mice.<fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.05098.010</object-id><label>Figure 3.</label><caption><title>HH-induced ventral foregut spheroids give rise to lung organoids.</title><p>(<bold>A</bold>) hESCs were differentiated into foregut spheroids by treating cells with 4 days of ACTA and then an additional 4–6 days of NOG+SB+FGF4+Ch with the addition of the HH agonist SAG. Representative whole mount images of spheroids in a matrigel droplet are shown at low (left, scale bar 200 µm) and high magnification (right, scale bar 100 µm). (<bold>B</bold>) The addition of SAG to the NOG+SB+FGF4+Ch spheres caused a reduction in <italic>SOX2</italic> and <italic>CDX2</italic> transcripts (top panel) and a significant increase of <italic>NKX2.1</italic> transcript (bottom panel) compared to NOG+SB+FGF4+Ch spheres (without SAG). Other foregut lineages (<italic>PAX8, PDX1, HHEX</italic>) were not significantly different when SAG was added. (<bold>C</bold>) The majority of the cells in NOG+SB+FGF4+Ch+SAG spheres expressed FOXA2, SOX2 and NKX2.1 protein. Scale bars represent 50 µm. (<bold>D</bold>) Timeline showing NOG+SB+FGF4+Ch+SAG induced foregut spheroids grown and maintained in FGF10. Note that Day 1 is the day spheroids were plated in Matrigel. The scale bar represents 100 µm. (<bold>E</bold>) Organoids express lung markers in a manner consistent with mouse lung development. All expression is shown relative to undifferentiated pluripotent stem cells (hPSC), and adult human lung is shown as a reference. Lung progenitor markers <italic>NMYC</italic> and <italic>ID2</italic> were very low in adult lung, and were expressed at high levels in early organoid cultures, but were reduced over time (D = Days in culture), whereas <italic>NKX2.1</italic> expression remained relatively constant. In contrast, <italic>SFTPC</italic> is known to be expressed at low levels in distal lung progenitors, but increases and is highly expressed in AECII cells. Consistently, <italic>SFTPC</italic> is highly expressed in adult human lungs and increases over time in organoid cultures and the AECI marker <italic>HOPX</italic> is also highly expressed in adult human lung and increases over time in organoids. *p &lt; 0.05. All error bars represent SEM.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.010">http://dx.doi.org/10.7554/eLife.05098.010</ext-link></p></caption><graphic xlink:href="elife-05098-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.011</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Overview of conditions tested to generate human lung organoids.</title><p>hPSCs are OCT4 and NANOG positive. After 4 days of 100 ng/ml Activin A, definitive endoderm (FOXA2 and SOX17 positive) was generated and then treated with two different conditions. In the top branch, NOG+SB+FGF4+Ch spheroids were generated, and different conditions were tested to promote lung organoid differentiation. In the bottom branch, NOG+SB+FGF4+Ch+SAG spheroids were generated, and different conditions were tested to promote lung organoid differentiation. Ultimately, we determined that spheroids generated with NOG+SB+FGF4+Ch+SAG and that were subsequently embedded in Matrigel and expanded in FGF10 gave rise to ‘Human Lung Organoids’ (HLOs).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.011">http://dx.doi.org/10.7554/eLife.05098.011</ext-link></p></caption><graphic xlink:href="elife-05098-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.012</object-id><label>Figure 3—figure supplement 2.</label><caption><title>FGF-low culture conditions cause a loss of organoid epithelium over time.</title><p>(<bold>A</bold>) NOG+SB+F+Ch foregut spheroids were generated and then cultured in SAG+SU for 10 days followed by 1% FBS ± FGF10. Timeline images show organoids cultured in 1% FBS. By day 20, 3D structures appeared ‘fuzzy’, which indicates an outgrowth of mesenchymal tissue. Scale bar represents 200 µm. (<bold>B</bold>) NOG+SB+F+Ch foregut spheroids treated with SAG+SU and maintained in 1% FBS showed an increase in Vimentin (VIM, green) immunofluorescence over time. Scale bar represents 50 µM. (<bold>C</bold>) NOG+SB+F+Ch foregut spheroids treated with SAG+SU and maintained in 1% FBS (upper panel) or 1% FBS+FGF10 (lower panel) had a significant increase of <italic>VIM</italic> expression starting at day 20 (D20) compared to hPSCs and showed very weak <italic>E-CADHERIN</italic> (<italic>CDH1)</italic> expression compared to D20 HLOS (optimized conditions, as described in <xref ref-type="fig" rid="fig3">Figure 3</xref>). Lastly, both conditions appeared to lose <italic>NKX2.1</italic> expression over time. (<bold>D</bold>) NOG+SB+F+Ch+SAG spheroids maintained in 1% FBS (basal media) also appear to lose epithelial structures over time. Scale bar represents 200 µm. (<bold>E</bold>) By day 20 (D20) the tissue had very few epithelial structures expressing ECAD (white, left panel) and there was robust VIM expression (green, right panel) at both time points. Scale bar represents 50 µm. HLO *p &lt; 0.05. All error bars represent SEM.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.012">http://dx.doi.org/10.7554/eLife.05098.012</ext-link></p></caption><graphic xlink:href="elife-05098-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.013</object-id><label>Figure 3—figure supplement 3.</label><caption><title>Foregut spheroids express lung and foregut specific markers.</title><p>(<bold>A</bold>) NOG/SB/FGF4/Ch/SAG spheroids coexpress NKX2.1 (green) and the endoderm marker FOXA2 (red). (<bold>B</bold>) The majority of the cells in the spheroid co-expresses SOX2 (green) and FOXA2 (red). Scale bars represent 50 µM.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.013">http://dx.doi.org/10.7554/eLife.05098.013</ext-link></p></caption><graphic xlink:href="elife-05098-fig3-figsupp3-v1.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.014</object-id><label>Figure 3—figure supplement 4.</label><caption><title>Ventral foregut spheroids do not express appreciable levels of PAX8 protein.</title><p>Although NOG+SB+FGF4+Ch+SAG ventral foregut spheroids expressed <italic>PAX8</italic> mRNA (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), we did not detect PAX8 protein in spheroids using immunofluorescence, whereas PAX8 protein in FGF2 8 day treated foregut monolayers (ACTA followed by NOG/SB) was readily detectable. Left panel: scale bar represents 50 µm. Right panel: scale bar represents 200 µm, inset scale bar represents 100 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.014">http://dx.doi.org/10.7554/eLife.05098.014</ext-link></p></caption><graphic xlink:href="elife-05098-fig3-figsupp4-v1.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.015</object-id><label>Figure 3—figure supplement 5.</label><caption><title>Foregut spheroids consist of both epithelial and mesenchymal cells.</title><p>NOG/SB/FGF4/Ch/SAG spheroids have a minor population of Vimentin (VIM, white) positive mesenchymal cells, while the majority of cells are epithelial and express ECAD (red). Scale bar represents 50 µM.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.015">http://dx.doi.org/10.7554/eLife.05098.015</ext-link></p></caption><graphic xlink:href="elife-05098-fig3-figsupp5-v1.tif"/></fig><fig id="fig3s6" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.016</object-id><label>Figure 3—figure supplement 6.</label><caption><title>Lung organoids contain both proximal and distal domains.</title><p>NOG/SB/FGF4/Ch/SAG spheroids cultured for 15 days with FGF10 express the distal lung epithelium marker SOX9 (green) and proximal marker SOX2 (white) as separate domains in the epithelium labeled by ECAD (red). Z-stack images are shown every 40 µm sections through the HLO. Scale bar represents 200 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.016">http://dx.doi.org/10.7554/eLife.05098.016</ext-link></p></caption><graphic xlink:href="elife-05098-fig3-figsupp6-v1.tif"/></fig></fig-group></p><p>We also observed a slight, but non-significant increase in <italic>PAX8</italic> transcript level in NOG/SB/F/Ch/SAG treated foregut spheroids (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Importantly, PAX8 protein expression was undetectable in NOG/SB/F/Ch/SAG treated foregut spheroids and expression remained low/undetectable throughout time in culture. (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>). Similar to NOG/SB/F/Ch treated spheroids, the NOG/SB/F/Ch/SAG treated spheroids had a minor population of cells within the spheroids of mesodermal in origin, expressing Vimentin (VIM) (<xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5</xref>).</p><p>NOG/SB/F/Ch/SAG treated foregut spheroids were embedded in Matrigel to provide a 3D growth environment. Spheroids maintained in basal media (see ‘Materials and methods’) supplemented with 1% FBS lost ECAD+ epithelial structures and were mainly comprised of mesenchyme within 20 days of 3D culture (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D,E</xref>). FGF10 is essential for branching morphogenesis and maintenance of lung progenitor cells during development as well as tissue homeostasis in the adult lung (<xref ref-type="bibr" rid="bib4">Bellusci et al., 1997a</xref>; <xref ref-type="bibr" rid="bib50">Min et al., 1998</xref>; <xref ref-type="bibr" rid="bib83">Weaver et al., 2000</xref>; <xref ref-type="bibr" rid="bib80">Volckaert et al., 2013</xref>). We observed that the addition of FGF10 (500 ng/ml) allowed spheroids to expand and be passaged for over 100 days. FGF10 promoted the maintenance of ECAD+ epithelial structures with less mesenchymal contributions compared to both basal and FGF inhibitor conditions (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). NOG/SB/F/Ch/SAG cultured for 15 days in FGF10 possessed abundant ECAD+ epithelium that expressed the proximal lung marker SOX2 and distal lung marker SOX9. SOX2+ domains and SOX9+ domains were distributed throughout the entire HLO as determined by whole mount immunofluorescence and confocal Z-sections. (<xref ref-type="fig" rid="fig3s6">Figure 3—figure supplement 6</xref>). FGF10 treated foregut spheroids maintained <italic>NKX2.1</italic> expression over time; however, consistent with mouse development, distal progenitor markers, <italic>NMYC</italic> and <italic>ID2</italic> mRNA expression decreased over time while distal Alveolar Type I and II cell markers, <italic>HOPX</italic> and <italic>SFTPC</italic> increased over time (<xref ref-type="bibr" rid="bib60">Okubo, 2005</xref>; <xref ref-type="bibr" rid="bib64">Rawlins et al., 2009</xref>) (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). These data suggest that HLOs pass through a stage resembling early fetal lung development in mice.</p></sec><sec id="s2-4"><title>HLOs possess proximal airway-like structures</title><p>HLOs cultured longer than 2 months had striking epithelial structures resembling proximal airways, expressing proximal cell type-specific markers, including basal cells (P63), ciliated cells (FOXJ1, ACTTUB) and club cells (SCGB1A1) (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Proximal-like airway tissues were often surrounded by a smooth muscle actin positive (SMA+) mesenchyme compartment. Although <italic>P63</italic> mRNA expression is maintained throughout culture (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), it is only in prolonged cultures (&gt;2 months) where the P63+ cells are spatially arranged along the basal side of the epithelial tube-like structures, adjacent to SMA+ mesenchyme, similar to human bronchi and bronchioles (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) (<xref ref-type="bibr" rid="bib6">Boers et al., 1998</xref>; <xref ref-type="bibr" rid="bib56">Nakajima et al., 1998</xref>; <xref ref-type="bibr" rid="bib23">Evans et al., 2001</xref>; <xref ref-type="bibr" rid="bib66">Rock et al., 2009</xref>). By 65 days in vitro (D65) proximal-like epithelial structures form a cyst-like structure that expresses P63, as determined by whole mount immunofluorescence staining and confocal z-stacks. Moreover, SMA expression is strongest at the periphery of the HLO (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). P63+ proximal airway-like cells also co-express SOX2 and NKX2.1 as determined on serial sections (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). Located on the luminal surface of HLO proximal airway-like structures are cells expressing the multi-ciliated cell transcription factor FOXJ1 (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Very few cells expressed the club cell marker SCGB1A1, and this protein was observed in a pixilated expression pattern (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Multi-ciliated and club cell specific mRNAs, <italic>FOXJ1</italic> and <italic>SCGB1A1</italic> respectively, were significantly increased in prolonged HLO culture (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Although the goblet cell marker <italic>MUC5AC</italic> mRNA expression was detected, protein expression was not detected by immunofluorescence (<xref ref-type="fig" rid="fig4">Figure 4A</xref> and data not shown).<fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.05098.017</object-id><label>Figure 4.</label><caption><title>Lung organoids form proximal airway-like structures.</title><p>(<bold>A</bold>) Genes expressed in the proximal airway were examined in organoids across time. The proximal airway cell marker <italic>SOX2</italic> decreased over time in HLOs cultures compared to D10 HLOs. Compared to undifferentiated hPSCs, organoids expressed high levels of the basal cell marker <italic>P63</italic> at all time points, while expression of the club cell marker <italic>SCGB1A1</italic> and ciliated cell marker <italic>FOXJ1</italic> increased significantly in prolonged cultures (compared to D10 HLOs). There was an increasing but non-significant trend in goblet cell <italic>MUC5AC</italic> expression over time in culture. (<bold>B</bold>) D65 HLOs had structures resembling the proximal airway, in which the epithelium (β-catenin, red) possesses P63+ basal cells (green), and is surrounded by SMA+ (white, upper and lower left panel) mesenchymal tissue. Adjacent to the P63 positive basal cell layer (green, lower, right panel) were FOXJ1 positive cells (white). Scale bars represent 50 µM (top) and 10 µM (bottom). (<bold>C</bold>) Proximal airway-like epithelium (β-catenin, green) co-stained for ACTTUB on the apical side of the cell (red). Scale bars represent 50 µM (top) and 10 µM (bottom). (<bold>D</bold>). Proximal airway-like epithelium (E-cadherin, red) also co-stained with Club cell marker CC10 (white, right panel). Scale bars represent 50 µM (top) and 10 µM (bottom). (<bold>E</bold>) Acellular human lung matrix was seeded with spheroids and cultured for 40 days (D40). Matrices had abundant proximal airway-like structures that had multi-ciliated cells on the apical surfaced labeled by ACTTUB (red, top panel) in low (scale bar 50 µM) and high magnification (scale bar 10 µM). Serial sections showed that cells were also FOXJ1 positive (white, lower panel) with the epithelium outlined in ECAD (green) in low (scale bar 50 µM) and high magnification (scale bar 10 µM). (<bold>B</bold>–<bold>D</bold>) ‘L’ in high magnification images indicates the lumen. *p &lt; 0.05. All error bars represent SEM.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.017">http://dx.doi.org/10.7554/eLife.05098.017</ext-link></p></caption><graphic xlink:href="elife-05098-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.018</object-id><label>Figure 4—figure supplement 1.</label><caption><title>Lung organoids have P63+ epithelium throughout the organoid.</title><p>(<bold>A</bold>) Confocal Z-slices taken at every 40 µm show P63+ (green) and ECAD+ (white) structures through the D65 HLO. (<bold>B</bold>) Z-slices taken at every 40 µm show SMA (white) surrounding the periphery the HLO with P63 (green) staining within the HLO. Scale bars represent 200 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.018">http://dx.doi.org/10.7554/eLife.05098.018</ext-link></p></caption><graphic xlink:href="elife-05098-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.019</object-id><label>Figure 4—figure supplement 2.</label><caption><title>P63+ cells have an NKX2.1+ lung identity.</title><p>(<bold>A</bold>) Serial sections were stained with NKX2.1 and P63 respectively. The adjacent sections expressed ECAD (white) and NKX2.1 (green) in the first section and P63 (green) in the second section. (<bold>B</bold>) P63+ cells (green) co-expressed the proximal lung marker SOX2 (red) in the epithelium labeled by ECAD (white). Scale bars represent 50 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.019">http://dx.doi.org/10.7554/eLife.05098.019</ext-link></p></caption><graphic xlink:href="elife-05098-fig4-figsupp2-v1.tif"/></fig></fig-group></p><p>Although the multi-ciliated cell transcription factor FOXJ1 was abundant in proximal airway-like structures, we observed that ACTTUB was localized to the apical side of these cells, but did not appear to be localized to cilia on the apical cell surface (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), suggesting that this may represent a cell that has not fully differentiated. Others have demonstrated that robust differentiation of multi-ciliated cells from hPSCs require modified culture conditions to promote differentiation of functional cell types (<xref ref-type="bibr" rid="bib24">Firth et al., 2014</xref>). Thus, it is possible that the HLO environment, such as Matrigel or media rich in FGF10, does not promote terminal differentiation of all cell types. In order to alter the HLO environment, we seeded NOG/SB/F/Ch/SAG foregut spheroids onto an acellular human lung matrix (<xref ref-type="bibr" rid="bib7">Booth et al., 2012</xref>). Spheroids seeded on slices of acellular lung matrix predominantly gave rise to proximal airway-like structures in which stereotypical tufts of ACTTUB positive ciliated structures on the apical surface of cells were observed facing into a lumen. In serial sections, these airways had abundant FOXJ1+ cells (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Thus, HLOs have the capacity to generate more mature ciliated cells given the correct stimulus or environment.</p><p>As noted, proximal airways are often closely associated with the SMA+ mesenchyme (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) whereas in the adult murine lung, proximal airways are also associated with Pdgfrα+ and Vim+ mesenchymal cells (<xref ref-type="bibr" rid="bib8">Boucherat et al., 2007</xref>; <xref ref-type="bibr" rid="bib30">Hinz et al., 2007</xref>; <xref ref-type="bibr" rid="bib13">Chen et al., 2012</xref>). Thus, we investigated the mesenchymal population within the HLOs in more detail. Immunofluorescence revealed that D65 HLOs have both PDGFRα+/VIM+ double positive and PDGFRα−/VIM+ cell populations, which is indicative of myofibroblasts and fibroblasts respectively (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Adult murine myofibroblasts also co-express Sma and Pdgfrα whereas differentiated smooth muscle is Sma+/Pdgfra− (<xref ref-type="bibr" rid="bib41">Leslie et al., 1990</xref>; <xref ref-type="bibr" rid="bib45">Low and White, 1998</xref>; <xref ref-type="bibr" rid="bib8">Boucherat et al., 2007</xref>; <xref ref-type="bibr" rid="bib30">Hinz et al., 2007</xref>; <xref ref-type="bibr" rid="bib13">Chen et al., 2012</xref>), and we observe PDGFRα+/SMA+ and PDGFRα−/SMA+ populations of cells indicating that HLOs possess myofibroblasts and smooth muscle cells (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). The HLOs did not stain positive for Safranin O indicating there is no cartilage tissue, whereas iPSC derived teratomas had abundant cartilage (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Taken together, the HLO mesenchymal population is diverse with myofibroblasts, fibroblasts, and smooth muscle cells.<fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.05098.020</object-id><label>Figure 5.</label><caption><title>Lung organoids possess multiple types of mesenchymal cells.</title><p>(<bold>A</bold>) D65 HLOs have PDGFRα+ (green) VIM+ (white) double-positive myofibroblasts and PDGFRα−/VIM+ fibroblasts. Scale bar represents 50 µm. (<bold>B</bold>) D65 HLOs also possesses PDGFRα+ (green) SMA+ (white) double-positive myofibroblasts and PDGFRα−/SMA+ smooth muscle and myofibrblasts. Scale bar represents 50 µm. (<bold>C</bold>) D65 HLOs do not contain any cartilage whereas positive control iPSC derived teratoma had clear Safranin O staining specific to cartilage. Fast green marks the cytoplasm and hematoxylin the nuclei of both tissues. Scale bar represents 100 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.020">http://dx.doi.org/10.7554/eLife.05098.020</ext-link></p></caption><graphic xlink:href="elife-05098-fig5-v1.tif"/></fig></p></sec><sec id="s2-5"><title>HLOs possess immature alveolar airway-like structures</title><p>The distal lung epithelium in mouse and human make up the gas-exchanging alveoli, consisting of type I and type II alveolar epithelial cells (AECI, AECII). During development, the distal lung epithelium expresses progenitor markers including SOX9, ID2, and NMYC (<xref ref-type="bibr" rid="bib60">Okubo, 2005</xref>; <xref ref-type="bibr" rid="bib64">Rawlins et al., 2009</xref>; <xref ref-type="bibr" rid="bib12">Chang et al., 2013</xref>; <xref ref-type="bibr" rid="bib67">Rockich et al., 2013</xref>). All distal markers are present in the HLOs; however, <italic>ID2</italic> and <italic>NMYC</italic> are expressed at high levels in early cultures, but are down regulated in prolonged culture (<xref ref-type="fig" rid="fig3">Figure 3F</xref>) while <italic>SOX9</italic> expression remains consistent across time in culture (<xref ref-type="fig" rid="fig6">Figure 6A</xref>).<fig-group><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.05098.021</object-id><label>Figure 6.</label><caption><title>Lung organoids possess abundant distal bipotent progenitor cells.</title><p>(<bold>A</bold>) The expression of the distal progenitor marker <italic>SOX9</italic> remained unchanged over time and expression of the AECI marker <italic>PDPN</italic> was low in HLO cultures. (<bold>B</bold>) The majority of SFTPC+ cells (green, left panel) co-expressed SOX9 (red). Similarly, many cells expressing the AECI early marker HOPX+ (green, right panel) co-expressed SOX9 (red). Few, scattered cells expressed the late AECII marker SFTPB (white, second panel) or the AECI marker, PDPN (third panel, white). Few PDPN+ cells also showed elongated, squamous morphology seen in the adult lung. (<bold>C</bold>) Human lung AECII cells labeled with SFTPC (green, left panel) did not co-express SOX9. SFTPB+ cells (white, second panel) in the adult human lung have similar morphology to SFTPB+ cells in HLOs. Human lung AECI cells expressed PDPN (white, third panel), and show characteristic AECI cell shape. Human AECI cells express HOPX (green, right panel), but did not co-express SOX9. (<bold>B</bold>–<bold>C</bold>) Scale bar in lower magnification images in B (upper panel) represent 50 µM and the scale bars in higher magnification images in <bold>B</bold>, <bold>C</bold> (lower panel) represent 10 µM. (<bold>D</bold>) D50 HLOs contain lamellar bodies which are organelles specific to AECII cells. Scale bars represent 500 nm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.021">http://dx.doi.org/10.7554/eLife.05098.021</ext-link></p></caption><graphic xlink:href="elife-05098-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.05098.022</object-id><label>Figure 6—figure supplement 1.</label><caption><title>SFTPC+ cells express lung specific markers.</title><p>D65 HLOs express lung epithelial markers NKX2.1 (green) and SOX9 (red) and the adjacent section expresses SFTPC (green) and SOX9 (red). Scale bar represents 50 µm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.022">http://dx.doi.org/10.7554/eLife.05098.022</ext-link></p></caption><graphic xlink:href="elife-05098-fig6-figsupp1-v1.tif"/></fig></fig-group></p><p>Recently, there have been major advances in mice toward defining a bipotent alveolar progenitor population during the late fetal/early neonatal period (<xref ref-type="bibr" rid="bib20">Desai et al., 2014</xref>; <xref ref-type="bibr" rid="bib78">Treutlein et al., 2014</xref>), and this work has highlighted the fact that many markers previously considered terminal differentiation markers are co-expressed in the bipotent progenitors. Specifically, the AECII marker SftpC and AECI marker Hopx can be co-expressed in a bipotent progenitor before becoming committed to one lineage or the other. Moreover, we have shown that Sox9 marks an early progenitor population in the developing mouse lung and Sox9 also marks the bipotent progenitor in late fetal life (<xref ref-type="bibr" rid="bib67">Rockich et al., 2013</xref>; <xref ref-type="bibr" rid="bib78">Treutlein et al., 2014</xref>). In HLOs grown in prolonged culture (&gt;2 months), we observed that AECII (SFTPC, SFTPB) and AECI (PDPN, HOPX) cell-type markers were present (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>). However, we also observed that <italic>SFTPC</italic> levels were very low (<xref ref-type="fig" rid="fig3">Figure 3F</xref>), and that SFTPB+ cells were rare (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). This suggested that the distal airway cells present in HLOs might be a progenitor-like population. To test this possibility, we co-stained SFTPC (AECII) or HOPX (AECI) with SOX9 and found abundant SFTPC/SOX9 and HOPX/SOX9 double positive cells (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Co-staining in serial sections suggests that SFTPC/SOX9 double positive cells are also NKX2.1+ (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). In contrast these co-expressing cells were not found in the adult human lung (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Although rare, the few SFTPB+ observed in HLOs resemble AECII cells seen in the adult human lung, and PDPN+ cells resembled the elongated AECI cells in the human lung (<xref ref-type="fig" rid="fig6">Figure 6B–C</xref>). In order to improve confidence that cells expressing AECII markers are AECII cells, we used transmission electron microscopy (TEM) to determine if HLOs possessed cells containing lamellar bodies, which are necessary for surfactant protein trafficking and secretion (<xref ref-type="bibr" rid="bib68">Schmitz and Müller, 1991</xref>; <xref ref-type="bibr" rid="bib73">Stahlman et al., 2000</xref>; <xref ref-type="bibr" rid="bib84">Weaver et al., 2002</xref>). Using TEM, we observed lamellar bodies both in cells within HLOs, and in open spaces between cells, indicating that lamellar bodies are being secreted (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Taken together, our data suggests that HLOs predominantly possess undifferentiated alveolar progenitor cells with rare differentiated AECI and AECII cells interspersed throughout the distal-like tissue.</p></sec><sec id="s2-6"><title>Quantitative assessment of HLO composition</title><p>We have shown that HLOs have both proximal-like and distal-like epithelium in addition to surrounding mesenchymal tissue. In order to better gauge the composition of HLOs, we performed a detailed quantitative analysis of cell types and structures. We sectioned 48 individual HLOs, and examined them for P63+ proximal airway-like structures (as shown in <xref ref-type="fig" rid="fig4">Figure 4B–D</xref>), and distal-airway like structures (as shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). We found that 39/48 (81%) of the HLOs have proximal airway epithelial structures while 48/48 (100%) of HLOs have distal airway-like structures (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). We then calculated the average cross-sectional area comprised of P63+ proximal airway-like and P63−/SFTPC+ distal airway-like tissue and found that proximal structures comprised 14.5% (±0.6%) of the entire area of the HLO, whereas 85.5% (±0.6%) were distal in nature (including epithelium and mesenchyme) (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). To determine the percentage of certain cell types within an HLO, we sectioned and stained 15 individual HLOs (n = 15) and counted cells positive for specific markers, and the total number of Dapi+ nuclei within a section (<xref ref-type="fig" rid="fig7">Figure 7C–G</xref>). On average, 57% of all cells in the HLOs were NKX2.1+ (<xref ref-type="fig" rid="fig7">Figure 7C</xref>), 39% of all cells were P63+, 3% were FOXJ1+, 5% were SFTPC+, and 4% of all cells were HOPX+ (<xref ref-type="fig" rid="fig7">Figure 7D–G</xref>).<fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.05098.023</object-id><label>Figure 7.</label><caption><title>Quantitative assessment of the composition of lung organoids.</title><p>(<bold>A</bold>) HLOs were assessed for proximal airway-like structures (P63+) and distal airway-like structures (P63−/SFTPC+). 81% of HLOs have proximal airway-like epithelium while 100% have distal airway-like epithelium (n = 48 individual HLOs). (<bold>B</bold>) The average cross-sectional area within an HLO that is comprised of P63+ proximal airway-like and P63−/SFTPC+ distal airway-like epithelium was calculated. Proximal structures comprised 14.5% (±0.6%) of the entire area of the HLO (P63+), whereas 85.5% (±0.6%) of HLO was distal-like epithelium and mesenchyme (P63−). (<bold>C</bold>–<bold>G</bold>) The percent of specific cell markers present in an organoid was determined by dividing by the total number of DAPI+ nuclei within the same section (n = 15 individual HLOs). Each point represents the data from an individual HLO while the open bar represents the average percent of cells. (<bold>C</bold>) On average, 57% of all cells in the HLOs were NKX2.1+, (<bold>D</bold>) 39% of all cells were P63+, (<bold>E</bold>) 3% were FOXJ1+, (<bold>F</bold>) 5% were SFTPC+, (<bold>G</bold>) 4% of all cells were HOPX+. (<bold>B</bold>–<bold>G</bold>) Error bars represent SEM.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.023">http://dx.doi.org/10.7554/eLife.05098.023</ext-link></p></caption><graphic xlink:href="elife-05098-fig7-v1.tif"/></fig></p></sec><sec id="s2-7"><title>HLOs are globally similar to human fetal lung</title><p>Accumulating evidence suggests that HLOs are immature. For example, distal progenitor markers are initially robustly expressed whereas SFTPC expression is very low across time in HLOs (<xref ref-type="fig" rid="fig3">Figure 3E</xref>), FOXJ1+ cells do not appear to form mature multi-ciliated structures until placed onto a decelluarized lung matrix (<xref ref-type="fig" rid="fig4">Figure 4B,E</xref>) and rare SCGB1A1+ cells do not resemble mature club cells (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Moreover, the majority of the distal-like epithelium expresses bipotent progenitor markers (<xref ref-type="fig" rid="fig5">Figure 5</xref>). In order to directly address the maturity of HLOs, we conducted RNA-sequencing (RNAseq) on HLOs (n = 6; 3 D65 HLOs, 3 D110 HLOs), on undifferentiated hESCs and on definitive endoderm. We also took advantage of publicly available RNAseq datasets for human fetal lung representing a range of gestational stages, and for adult human lung (<xref ref-type="supplementary-material" rid="SD1-data">Supplementary file 1</xref>). In order to determine global similarity among these tissues relative to HLOs, we conducted principal component (PC) analysis (<xref ref-type="fig" rid="fig8">Figure 8A,B</xref>) (<xref ref-type="bibr" rid="bib65">Ringnér, 2008</xref>), hierarchical clustering (<xref ref-type="fig" rid="fig8">Figure 8C</xref>) (<xref ref-type="bibr" rid="bib22">Eisen et al., 1998</xref>) and Spearman's rank-order correlation (<xref ref-type="bibr" rid="bib33">Jiang et al., 2004</xref>) matrix analysis (<xref ref-type="fig" rid="fig8">Figure 8D</xref>) of the complete tabulated FPKM matrix generated from RNA sequences datasets and representing the total gene expression complement in each sample. Consistent across all three types of informatics analysis, transcriptional activity in the HLOs shares the greatest degree of similarity to human fetal lung. These data strongly suggest that global transcription of HLOs is highly similar to human fetal lung, and support the idea that HLOs are in a less differentiated, fetal state when grown in the conditions described here.<fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.05098.024</object-id><label>Figure 8.</label><caption><title>RNA sequencing analysis associates HLOs with fetal lung tissue.</title><p>6 HLOs (n = 3 D65 HLOs and n = 3 D110 HLOs) were compared to the undifferentiated H9 stem cells (SC) and definitive endoderm (Def End) and publicly available datasets of adult and fetal human lungs (see <xref ref-type="supplementary-material" rid="SD1-data">Supplementary file 1</xref>). (<bold>A</bold>–<bold>B</bold>) Plot of the first three principle components generated in the principle component (PC) analysis as pairwise 2-dimensional plots (<bold>A</bold>) or as an aggregate 3-dimensional projection (<bold>B</bold>), (<bold>C</bold>) hierarchical clustering, and (<bold>D</bold>) Spearman's correlation all demonstrate that HLOs are most closely related to the fetal lung.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.024">http://dx.doi.org/10.7554/eLife.05098.024</ext-link></p></caption><graphic xlink:href="elife-05098-fig8-v1.tif"/></fig></p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>To date, a number of groups have defined methods to generate lung specific cell types utilizing 2D culture systems (<xref ref-type="bibr" rid="bib27">Green et al., 2011</xref>; <xref ref-type="bibr" rid="bib44">Longmire et al., 2012</xref>; <xref ref-type="bibr" rid="bib55">Mou et al., 2012</xref>; <xref ref-type="bibr" rid="bib87">Wong et al., 2012</xref>; <xref ref-type="bibr" rid="bib26">Ghaedi et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Huang et al., 2013</xref>). Although lung lineage cells have been generated with varying efficiency (∼30–80% NKX2.1+ cells [<xref ref-type="bibr" rid="bib87">Wong et al., 2012</xref>; <xref ref-type="bibr" rid="bib32">Huang et al., 2013</xref>; <xref ref-type="bibr" rid="bib24">Firth et al., 2014</xref>]) and can generate both both proximal (∼5–36% of cells [<xref ref-type="bibr" rid="bib87">Wong et al., 2012</xref>; <xref ref-type="bibr" rid="bib32">Huang et al., 2013</xref>; <xref ref-type="bibr" rid="bib24">Firth et al., 2014</xref>]) and distal cell types (up to ∼50% of cells [<xref ref-type="bibr" rid="bib32">Huang et al., 2013</xref>]), proper spatial organization of the cell types and specific tissue morphology have not been reported in 2D systems. Here, we show that HLOs possess both mesenchymal and lung epithelial (∼60% NKX2.1+) cells with proximal airway-like structures that possess P63+ (∼40%) and FOXJ1+ cells (∼3%) along with distal airway-like structures that possess SFTPC+ (∼5%) and HOPX+ (∼4%) cells.</p><p>It is currently unclear if 2D culture systems described have the capability to give rise to mesodermal lineages. Thus, HLOs allow one to address questions regarding spatial tissue organization and epithelial-mesenchymal interactions. Since HLOs form organized structures that resemble bronchi and bronchioles with adjacent mesenchyme, these complex, organized tissues may allow exploration, for example, of airway remodeling after injury. Moreover, the spatial arrangement of specific cell types will be critical to study proximal airway dynamics during homeostasis and injury. For example, the location of P63+ cells adjacent to FOXJ1+ cells in the HLOs will be necessary to study basal cell differentiation into different proximal airway cell types during homeostasis or after injury. In addition to tissue morphology and structure during prolonged culture, the HLOs consist of both epithelium and mesenchyme in early cultures that are maintained over time. Since lung development requires extensive cross talk between the epithelium and mesenchyme in order to regulate developmental processes, proliferation and differentiation, HLOs may be an ideal in vitro system to study these complex tissue–tissue interactions.</p><p>Recently, there has been a push to define progenitor populations during lung development and adult homeostasis in order to better understand differentiation and the transition between branching and alveolarization. Two groups have defined a bipotent progenitor population in the embryonic/neonatal lung that gives rise to both AECI and AECII cells (<xref ref-type="bibr" rid="bib20">Desai et al., 2014</xref>; <xref ref-type="bibr" rid="bib78">Treutlein et al., 2014</xref>). These bipotent cells express the distal progenitor marker Sox9 along with differentiation markers of AECI and AECII cells, including SftpC, HopX, and Pdpn. We demonstrate that HLOs expressed both AECI and II markers; however, the majority of these cells also expressed SOX9 suggesting that the majority of the distal epithelium is comprised of bipotent progenitors. Thus, HLOs will allow us to gain insight into this bipotent population, explore how bipotent progenitors are regulated, and define the mechanisms of how fate-decisions are made as terminal differentiation occurs.</p><p>The evidence supporting that HLOs are fetal in nature could reflect the fact that a block to full maturation exists in vitro, as is the case with other endoderm lineage organoids (intestinal and gastric), which appear to be immature. That is, while they possess committed lineage-specific cell types, the cells may not exhibit fully matured adult-like function (<xref ref-type="bibr" rid="bib48">McCracken et al., 2014</xref>; <xref ref-type="bibr" rid="bib82">Watson et al., 2014</xref>). This is also the case for pancreatic β-like cells and hepatocyte-like cells generated in vitro (<xref ref-type="bibr" rid="bib70">Si-Tayeb et al., 2009</xref>; <xref ref-type="bibr" rid="bib31">Hrvatin et al., 2014</xref>). Alternatively, the progenitor state may reflect the high levels of FGF10 in the culture media, since FGF10 is known to maintain progenitor cells in the lung (<xref ref-type="bibr" rid="bib62">Ramasamy et al., 2007</xref>; <xref ref-type="bibr" rid="bib59">Nyeng et al., 2008</xref>). Given that HLOs are similar to human fetal lung, this tissue is an ideal model to study lung maturation of both the proximal and distal epithelium along with epithelial-mesenchymal interactions in a developmental context.</p><p>While the multi-lineage, multi-cellular composition of HLOs is a major advantage, one of the caveats to this system is that HLOs do not appear to undergo <italic>bona fide</italic> branching morphogenesis or possess transitional zones found in the adult lung, such as the bronchioalveolar ductal junction (BADJ). The HLOs possess proximal SOX2+ domain and distal SOX9+ domains observed during branching morphogenesis, but this regionalization occurs without setting up the stereotyped branching pattern. This may be due to the fact that the organoids are surrounded by media supplemented with FGF10 compared to the in vivo situation where FGF10 is expressed in a dynamic, spatially restricted manner in the distal mesenchyme (<xref ref-type="bibr" rid="bib5">Bellusci et al., 1997b</xref>; <xref ref-type="bibr" rid="bib59">Nyeng et al., 2008</xref>; <xref ref-type="bibr" rid="bib1">Abler et al., 2009</xref>). However, it has recently been demonstrated that localized expression FGF10 is not required for branching (<xref ref-type="bibr" rid="bib80">Volckaert et al., 2013</xref>), so this may not explain the lack of branching. Alternatively, similar to other endoderm-derived organoid models, HLOs lack several components of the native organ, including immune cells, vasculature, and innervation. Thus, it is possible that cellular inputs important for branching morphogenesis are missing from HLOs. Indeed, recent reports have shown that innervation is required for proper branching (<xref ref-type="bibr" rid="bib9">Bower et al., 2014</xref>), and while vasculature may not be important for lung branching (<xref ref-type="bibr" rid="bib28">Havrilak and Shannon, 2015</xref>), others have shown the vascular endothelium is required to induce a branching-like program of isolated airway epithelium in 3D cultures (<xref ref-type="bibr" rid="bib25">Franzdóttir et al., 2010</xref>). Lastly, the microenvironment is essential for branching morphogenesis to occur including dynamic changes in the extracellular matrix around branching lung bud tips where the ECM is constantly changing and interacting with the cytoskeleton of the branching epithelium in order to facilitate cell movement and branching bifurcations (<xref ref-type="bibr" rid="bib52">Moore et al., 2005</xref>; <xref ref-type="bibr" rid="bib35">Kim and Nelson, 2012</xref>; <xref ref-type="bibr" rid="bib81">Wan et al., 2013</xref>). It is possible that in the future, co-culture with additional cellular inputs may prove to enhance HLO branching.</p><p>Taken together, we describe here a novel system to generate human lung organoids from human pluripotent stem cells. HLOs possess both mesenchymal and epithelial lineages, as well as organized proximal airway structures with multiple cell types and surrounded by mesenchyme. HLOs also possess distal epithelial cells that are reminiscent of a bipotent alveolar progenitor cell recently described in mice which is likely a reflection of the similarities of HLOs to the human fetal lung. We believe that HLOs will be an excellent new human system to model lung differentiation, homeostasis and disease in vitro.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Maintenance of hESCs</title><p>Human ES cell lines H1 (NIH registry #0043) and H9 (NIH registry #0062) were obtained from WiCell Research Institute. Human ES line UM77-2 (NIH registry #0278) was obtained from the University of Michigan. iPSC lines 3-5 and 20-1 were generated at Cincinnati Children's Hospital and have been previously described (<xref ref-type="bibr" rid="bib72">Spence et al., 2011</xref>). Stem cells were maintained on Matrigel (BD Biosciences, San Jose, CA) in mTeSR1 medium (STEMCELL Technologies, Vancouver, Canada). HESCs were passaged as previously described (<xref ref-type="bibr" rid="bib72">Spence et al., 2011</xref>).</p></sec><sec id="s4-2"><title>Differentiation of PSCs into definitive endoderm</title><p>Differentiation into definitive endoderm was carried out as previously described (<xref ref-type="bibr" rid="bib16">D'Amour et al., 2005</xref>; <xref ref-type="bibr" rid="bib72">Spence et al., 2011</xref>). Briefly, a 4-day Activin A (R&amp;D systems, Minneapolis, MN) differentiation protocol was used. Cells were treated with Activin A (100 ng ml<sup>−1</sup>) for 3 consecutive days in RPMI 1640 media (Life Technologies, Grand Island, NY) with increasing concentrations of 0%, 0.2% and 2% HyClone defined fetal bovine serum (dFBS, Thermo Scientific, West Palm Beach, FL).</p></sec><sec id="s4-3"><title>Differentiation of definitive endoderm into anterior foregut</title><p>After differentiation into definitive endoderm, foregut endoderm was differentiated, essentially as described (<xref ref-type="bibr" rid="bib27">Green et al., 2011</xref>). Briefly, cells were incubated in foregut media: Advanced DMEM/F12 plus N-2 and B27 supplement, 10 mM Hepes, 1× L-Glutamine (200 mM), 1× Penicillin-streptomycin (5000 U/ml, all from Life Technologies) with 200 ng/ml Noggin (NOG, R&amp;D Systems) and 10 µM SB431542 (SB, Stemgent, Cambridge, MA) for 4 days. For long term maintenance, cultures were maintain in ‘basal’ foregut media without NOG and SB, or in the presence of growth factors including 50, 500 ng/ml FGF2 (R&amp;D systems), 10 µM Sant-2 (Stemgent), 10 µM SU5402 (SU, Stemgent), 100 ng/ml SHH (R&amp;D systems), and SAG (Enzo Life Sciences, Farmingdale, NY) for 8 days.</p></sec><sec id="s4-4"><title>Directed differentiation into anterior foregut spheroids and lung organoids</title><p>After differentiation into definitive endoderm, cells were incubated in foregut media with NOG, SB, 500 ng/ml FGF4 (R&amp;D Systems), and 2 µM CHIR99021 (Chiron, Stemgent) for 4–6 days. After 4 days with treatment of growth factors, three-dimensional floating spheroids were present in the culture. Three-dimensional spheroids were transferred into Matrigel to support 3D growth as previously described (<xref ref-type="bibr" rid="bib47">McCracken et al., 2011</xref>). Briefly, spheroids were embedded in a droplet of Matrigel (BD Bioscience #356237) in one well of a 24 well plate, and incubated at room temperature for 10 min. After the Matrigel solidified, foregut media with 1% Fetal bovine serum (FBS, CAT#: 16000–044, Life Technologies) or other growth factors and small molecules were overlaid and replaced every 4 days. Organoids were transferred into new Matrigel droplets every 10–15 days.</p></sec><sec id="s4-5"><title>Immunohistochemistry</title><p>Immunostaining was carried out as previously described (<xref ref-type="bibr" rid="bib71">Spence et al., 2009</xref>; <xref ref-type="bibr" rid="bib67">Rockich et al., 2013</xref>). Antibody information and dilutions can be found in <xref ref-type="supplementary-material" rid="SD2-data">Supplementary file 2</xref>. All images were taken on a Nikon A1 confocal microscope or an Olympus IX71 epifluorescent microscope.</p></sec><sec id="s4-6"><title>RNA extraction and qRT-PCR</title><p>RNA was extracted from monolayers, spheroids, and organoids using a MagMAX-96 Total RNA Isolation Kit (Life Technologies) and MAG Max Express (Applied Biosystems, Grand Island, NY). RNA quantity and quality were determined spectrophotometrically, using a Nano Drop 2000 (Thermoscientific). Reverse transcription was conducted using the SuperScript VILO kit (Invitrogen, Grand Island, NY), according to manufacturer's protocol. Finally, qRT-PCR was carried out using Quantitect Sybr Green MasterMix (Qiagen) on a Step One Plus Real-Time PCR system (Life Technologies). For a list of primer sequences see <xref ref-type="supplementary-material" rid="SD3-data">Supplementary file 3</xref>.</p></sec><sec id="s4-7"><title>Seeding lung spheroids on decellularized human lung matrices</title><p>Human lungs deemed to be unsuitable for lung transplantation were obtained from beating-heart (or warm autopsy) donors through Gift of Life Michigan and lungs were decellularized as previously described (<xref ref-type="bibr" rid="bib7">Booth et al., 2012</xref>). Slices were prepared using a sterile tissue punch (Fisher) and sterilized with 0.18% peracetic acid and 4.8% EtOH. Matrix slices were placed in a 96 well plate and approximately 50 NOG+SB+F+Ch+SAG spheres were pipetted directly onto the matrices. Samples were centrifuged for 2 min at 2000 rpm and then incubated at 37°C for 30 min without media. Foregut media supplemented with 1% FBS and 500 ng/ml FGF10 was then added to the matrices. Media was changed daily.</p></sec><sec id="s4-8"><title>Transmission electron microscopy</title><p>D50 HLOs were processed as previously described (<xref ref-type="bibr" rid="bib61">Prasov et al., 2012</xref>; <xref ref-type="bibr" rid="bib67">Rockich et al., 2013</xref>). 70 nm sections were sections were imaged using a Philips CM-100 electron microscope.</p></sec><sec id="s4-9"><title>Area and cell quantification</title><p>HLOs with P63+ cells were counted as having proximal airway-like epithelium and HLOs with SFTPC+ cells were counted as having distal airway-like epithelium. The area of proximal epithelium was determined by P63+ECAD+ staining. Area was measured using ImageJ software. Cell quantification of NKX2.1, P63, and DAPI was counted by Metamorph cell counting software. FOXJ1, SFTPC, and HOPX were counted in ImageJ using the cell counter plugin.</p></sec><sec id="s4-10"><title>Statistical analysis and experimental replicates</title><p>All immunofluorescence and qRT-PCR experiments were carried out at least two times with three (n = 3) independent biological samples per experiment. The only exceptions to this were experiments that included human adult lung samples in the analysis. For these experiments, n = 1 biological human lung sample was used in statistical replicates (triplicates) whereas all other samples used biological replicates (n = 3). For quantification in <xref ref-type="fig" rid="fig7">Figure 7</xref>, a total of 48 different HLOs (n = 48) were counted for HLO composition. For the proximal epithelial area, 29 different HLOs were counted (n = 29). For cell quantification, 15 different HLOs were counted (n = 15). Statistical differences between groups were assessed with Prism software, using multiple t tests. All error bars represent SEM. Results were considered statistically significant at p &lt; 0.05.</p></sec><sec id="s4-11"><title>RNA sequencing and analysis</title><p>Sequencing of HLOs (n = 3 D65, n = 3 D110) was performed by the University of Michigan DNA Sequencing Core, using the Illumina Hi-Seq platform. Sequencing of H9 Stem Cells (SC) and Definitive Endoderm (DE) was performed by the University of California, San Francisco DNA Sequencing Core using the Illumina Hi-Seq platform. All sequences were deposited in the EMBL-EBI ArrayExpress database using Annotare 2.0 and are catalogued under the accession number E-MTAB-3339 for the HLOs and E-MTAB-3158 for SC and DE. The University of Michigan Bioinformatics Core obtained the reads files and concatenated those into a single ‘.fastq’ file for each sample. The Bioinformatics Core also downloaded reads files from EBI-AE database (Adult lung Samples) and NCBI-GEO (SRA) database (Fetal lung samples) (<xref ref-type="supplementary-material" rid="SD1-data">Supplementary file 1</xref>). The quality of the raw reads data for each sample was evaluated using FastQC (version 0.10.1) to identify features of the data that may indicate quality problems (e.g., low quality scores, over-represented sequences, inappropriate GC content, etc). Initial QC report indicated over-representation of Illumina adapter sequences in samples from EBI-AE data set and NCBI-GEO data set. Adapter sequences were trimmed from the reads using Cutadapt (version 0.9.5) (<xref ref-type="bibr" rid="bib15">Chen et al., 2014a</xref>). Briefly, reads were aligned to the reference transcriptome (UCSC hg19) using TopHat (version 2.0.9) and Bowtie (version 2.1.0.0) (<xref ref-type="bibr" rid="bib40">Langmead et al., 2009</xref>). Cufflinks/CuffNorm (version 2.2.1) was used for expression quantitation and differential expression analysis (<xref ref-type="bibr" rid="bib77">Trapnell et al., 2012</xref>), using UCSC hg19.fa as the reference genome sequence and UCSC hg19.gtf as the reference transcriptome annotation. For this analysis, we used parameter settings: ‘–multi-read-correct’ to adjust expression calculations for reads that map in more than one locus, as well as ‘–compatible-hits-norm’ and ‘–upper-quartile –norm’ for normalization of expression values. Normalized FPKM tables were generated using the CuffNorm function found in Cufflinks. Transcriptional quantitation analysis in Cufflinks was conducted using the 64-bit Debian Linux stable version 7.8 (‘Wheezy’) platform. The complete FPKM matrix, containing frequency counts for all 24,010 genes contained in the reference genome for all 23 RNAseq samples, was evaluated using unscaled principle component analysis (PCA) to visualize and quantify multi-dimensional variation between samples (<xref ref-type="bibr" rid="bib65">Ringnér, 2008</xref>). Of the 24,010 genes annotated in the reference genome, 2815 (11.7%) were not detected in the RNAseq analysis of any of the 23 samples. Principle components were calculated using the function ‘prcomp’ found in the R (version 3.1.2) statistical programming language (<ext-link ext-link-type="uri" xlink:href="http://www.R-project.org/">http://www.R-project.org/</ext-link>) and plotted using the R package ‘ggplot2’ (<xref ref-type="bibr" rid="bib86">Wickham, 2009</xref>). Hierarchical cluster analysis based on the Canberra distance (<xref ref-type="bibr" rid="bib22">Eisen et al., 1998</xref>) between FPKM vectors was used to classify discrete RNAseq samples according to the degree of total transcriptional dissimilarity indicated by the normalized FPKM values. Bootstrap analysis was used to assess the uncertainty in the assigned hierarchical clustering relationships. 10,000 bootstraping iterations were generated by repeatedly randomly sampling the FPKM dataset. The bootstrap probability (BP) of a cluster is defined as the frequency of a given relationship among the bootstrap replicates. Multiscale bootstrap resampling was used to calculate an approximately unbiased (AU) p-value for a given relationship, with AU &gt; 95 indicating a high degree of statistical significance. Analyses were conducted using R package ‘pvclust’ (<xref ref-type="bibr" rid="bib75">Suzuki and Shimodaira, 2006</xref>). Spearman correlation was applied as an additional assessment of the cumulative degree of correlation among RNAseq datasets. In addition, we computed Spearman rank correlation coefficients (ρ) in a pairwise manner among all 23 RNAseq samples using the complete normalized FPKM data. The Spearman coefficients were plotted as a heatmap using the function ‘heatmap.2’ in the R package ‘gplots’ (<ext-link ext-link-type="uri" xlink:href="http://cran.r-project.org/package=gplots">http://CRAN.R-project.org/package=gplots</ext-link>). Complete data analysis scripts are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/hilldr/HLO_eLife2015">https://github.com/hilldr/HLO_eLife2015</ext-link>.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>JRS is supported by the NHLBI (R21HL115372, R01HL119215), and by career development grants from the NIDDK (K01DK091415) and the March of Dimes (Basil O'Connor starter scholar award).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>BRD, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con2"><p>JRS, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con3"><p>DRH, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con4"><p>MAHF, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con13"><p>YHT, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con5"><p>MSN, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con6"><p>RD, Acquisition of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con7"><p>JMW, Conception and design, Edited and approved the final manuscript</p></fn><fn fn-type="con" id="con8"><p>CNM, Conducted teratoma assays, Provided teratoma tissue, Editing and approving manuscript</p></fn><fn fn-type="con" id="con9"><p>RN, Conducted experiments to generate RNAseq data (ES cells, Definitive Endoderm), Conducted RNA sequencing and provided the data files, Edited and approved the final manuscript</p></fn><fn fn-type="con" id="con10"><p>ODK, Conducted experiments to generate RNAseq data (ES cells, Definitive Endoderm), Conducted RNA sequencing and provided the data files, Edited and approved the final manuscript</p></fn><fn fn-type="con" id="con11"><p>ESW, Provided critical intellectual and material contributions to the study</p></fn><fn fn-type="con" id="con12"><p>GHD, Conception and design</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="SD1-data"><object-id pub-id-type="doi">10.7554/eLife.05098.025</object-id><label>Supplementary file 1.</label><caption><p>Publicly available RNAseq datasets for human fetal lung representing a range of gestational stages and for adult human lung.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.025">http://dx.doi.org/10.7554/eLife.05098.025</ext-link></p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-05098-supp1-v1.docx"/></supplementary-material><supplementary-material id="SD2-data"><object-id pub-id-type="doi">10.7554/eLife.05098.026</object-id><label>Supplementary file 2.</label><caption><p>Antibody information and dilutions.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.026">http://dx.doi.org/10.7554/eLife.05098.026</ext-link></p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-05098-supp2-v1.docx"/></supplementary-material><supplementary-material id="SD3-data"><object-id pub-id-type="doi">10.7554/eLife.05098.027</object-id><label>Supplementary file 3.</label><caption><p>Primer sequences.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.05098.027">http://dx.doi.org/10.7554/eLife.05098.027</ext-link></p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-05098-supp3-v1.docx"/></supplementary-material><sec id="s6-1" sec-type="datasets"><title>Major datasets</title><p>The following datasets were generated:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3339/" source-id-type="uri"><collab collab-type="author">Hill D</collab>, <collab collab-type="author">Spence J</collab>, <year>2015</year><x>, </x><source>Transcriptional characterization of Human Lung Organoids (HLOs) using RNAseq</source><x>, </x><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3339/">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3339/</ext-link><x>, </x><comment>Publicly available at EMBL ArrayExpress (E-MTAB-3339).</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataro2" source-id="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3158/" source-id-type="uri"><collab collab-type="author">Finkbeiner S</collab>, <collab collab-type="author">Spence J</collab>, <year>2014</year><x>, </x><source>Transcriptional Profiling of human pluripotent stem cells and and derived tissues</source><x>, </x><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3158/">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3158/</ext-link><x>, </x><comment>Publicly available at EMBL ArrayExpress (E-MTAB-3158).</comment></related-object></p><p>The following previously published datasets were used:</p><p><related-object content-type="existing-dataset" id="dataro3" source-id="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18927" source-id-type="uri"><collab collab-type="author">Stamatoyannopoulos J</collab>, <year>2010</year><x>, </x><source>University of Washington Human Reference Epigenome Mapping Project</source><x>, </x><object-id pub-id-type="art-access-id">Roadmap Epigenomics Series</object-id><x>; </x><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18927">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18927</ext-link><x>, </x><comment>Publicly available at NCBI Gene Expression Omnibus (GSE18927).</comment></related-object></p><p><related-object content-type="existing-dataset" id="dataro4" source-id="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1733/" source-id-type="uri"><collab collab-type="author">Hallstrom BM</collab>, <year>2013</year><x>, </x><source>RNA-seq of coding RNA from tissue samples of 95 human individuals representing 27 different tissues in order to determine tissue-specificity of all protein-coding genes</source><x>, </x><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1733/">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1733/</ext-link><x>, </x><comment>Publicly available at EMBL ArrayExpress (E-MTAB-1733).</comment></related-object></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abler</surname><given-names>LL</given-names></name><name><surname>Mansour</surname><given-names>SL</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name></person-group><year>2009</year><article-title>Conditional gene inactivation reveals roles for Fgf10 and Fgfr2 in establishing a normal pattern of epithelial branching in the mouse lung</article-title><source>Developmental Dynamics</source><volume>238</volume><fpage>1999</fpage><lpage>2013</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22032</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agha El</surname><given-names>E</given-names></name><name><surname>Herold</surname><given-names>S</given-names></name><name><surname>Alam Al</surname><given-names>D</given-names></name><name><surname>Quantius</surname><given-names>J</given-names></name><name><surname>MacKenzie</surname><given-names>B</given-names></name><name><surname>Carraro</surname><given-names>G</given-names></name><name><surname>Moiseenko</surname><given-names>A</given-names></name><name><surname>Chao</surname><given-names>CM</given-names></name><name><surname>Minoo</surname><given-names>P</given-names></name><name><surname>Seeger</surname><given-names>W</given-names></name><name><surname>Bellusci</surname><given-names>S</given-names></name></person-group><year>2013</year><article-title>Fgf10-positive cells represent a progenitor cell population during lung development and postnatally</article-title><source>Development</source><volume>141</volume><fpage>296</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1242/dev.099747</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ang</surname><given-names>SL</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name></person-group><year>1994</year><article-title>HNF-3 beta is essential for node and notochord formation in mouse development</article-title><source>Cell</source><volume>78</volume><fpage>561</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(94)90522-3</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellusci</surname><given-names>S</given-names></name><name><surname>Furuta</surname><given-names>Y</given-names></name><name><surname>Rush</surname><given-names>MG</given-names></name><name><surname>Henderson</surname><given-names>R</given-names></name><name><surname>Winnier</surname><given-names>G</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group><year>1997a</year><article-title>Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis</article-title><source>Development</source><volume>124</volume><fpage>53</fpage><lpage>63</lpage></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellusci</surname><given-names>S</given-names></name><name><surname>Grindley</surname><given-names>J</given-names></name><name><surname>Emoto</surname><given-names>H</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group><year>1997b</year><article-title>Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung</article-title><source>Development</source><volume>124</volume><fpage>4867</fpage><lpage>4878</lpage></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boers</surname><given-names>JE</given-names></name><name><surname>Ambergen</surname><given-names>AW</given-names></name><name><surname>Thunnissen</surname><given-names>FB</given-names></name></person-group><year>1998</year><article-title>Number and proliferation of basal and parabasal cells in normal human airway epithelium</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>157</volume><fpage>2000</fpage><lpage>2006</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.157.6.9707011</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>AJ</given-names></name><name><surname>Hadley</surname><given-names>R</given-names></name><name><surname>Cornett</surname><given-names>AM</given-names></name><name><surname>Dreffs</surname><given-names>AA</given-names></name><name><surname>Matthes</surname><given-names>SA</given-names></name><name><surname>Tsui</surname><given-names>JL</given-names></name><name><surname>Weiss</surname><given-names>K</given-names></name><name><surname>Horowitz</surname><given-names>JC</given-names></name><name><surname>Fiore</surname><given-names>VF</given-names></name><name><surname>Barker</surname><given-names>TH</given-names></name><name><surname>Moore</surname><given-names>BB</given-names></name><name><surname>Martinez</surname><given-names>FJ</given-names></name><name><surname>Niklason</surname><given-names>LE</given-names></name><name><surname>White</surname><given-names>ES</given-names></name></person-group><year>2012</year><article-title>Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>186</volume><fpage>866</fpage><lpage>876</lpage><pub-id pub-id-type="doi">10.1164/rccm.201204-0754OC</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boucherat</surname><given-names>O</given-names></name><name><surname>Benachi</surname><given-names>A</given-names></name><name><surname>Barlier-Mur</surname><given-names>AM</given-names></name><name><surname>Franco-Montoya</surname><given-names>ML</given-names></name><name><surname>Martinovic</surname><given-names>J</given-names></name><name><surname>Thébaud</surname><given-names>B</given-names></name><name><surname>Chailley-Heu</surname><given-names>B</given-names></name><name><surname>Bourbon</surname><given-names>JR</given-names></name></person-group><year>2007</year><article-title>Decreased lung fibroblast growth factor 18 and elastin in human congenital diaphragmatic hernia and animal models</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>175</volume><fpage>1066</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1164/rccm.200601-050OC</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bower</surname><given-names>DV</given-names></name><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Lansford</surname><given-names>R</given-names></name><name><surname>Zinn</surname><given-names>K</given-names></name><name><surname>Warburton</surname><given-names>D</given-names></name><name><surname>Fraser</surname><given-names>SE</given-names></name><name><surname>Jesudason</surname><given-names>EC</given-names></name></person-group><year>2014</year><article-title>Airway branching has conserved needs for local parasympathetic innervation but not neurotransmission</article-title><source>BMC Biology</source><volume>12</volume><fpage>92</fpage><pub-id pub-id-type="doi">10.1186/s12915-014-0092-2</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carré</surname><given-names>A</given-names></name><name><surname>Szinnai</surname><given-names>G</given-names></name><name><surname>Castanet</surname><given-names>M</given-names></name><name><surname>Sura-Trueba</surname><given-names>S</given-names></name><name><surname>Tron</surname><given-names>E</given-names></name><name><surname>Broutin-L'Hermite</surname><given-names>I</given-names></name><name><surname>Barat</surname><given-names>P</given-names></name><name><surname>Goizet</surname><given-names>C</given-names></name><name><surname>Lacombe</surname><given-names>D</given-names></name><name><surname>Moutard</surname><given-names>ML</given-names></name><name><surname>Raybaud</surname><given-names>C</given-names></name><name><surname>Raynaud-Ravni</surname><given-names>C</given-names></name><name><surname>Romana</surname><given-names>S</given-names></name><name><surname>Ythier</surname><given-names>H</given-names></name><name><surname>Léger</surname><given-names>J</given-names></name><name><surname>Polak</surname><given-names>M</given-names></name></person-group><year>2009</year><article-title>Five new TTF1/NKX2.1 mutations in brain–lung–thyroid syndrome: rescue by PAX8 synergism in one case</article-title><source>Human molecular genetics</source><volume>18</volume><fpage>2266</fpage><lpage>2276</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp162</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>SM</given-names></name><name><surname>Fasano</surname><given-names>CA</given-names></name><name><surname>Papapetrou</surname><given-names>EP</given-names></name><name><surname>Tomishima</surname><given-names>M</given-names></name><name><surname>Sadelain</surname><given-names>M</given-names></name><name><surname>Studer</surname><given-names>L</given-names></name></person-group><year>2009</year><article-title>Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling</article-title><source>Nature Biotechnology</source><volume>27</volume><fpage>275</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/nbt.1529</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>DR</given-names></name><name><surname>Martinez Alanis</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>RK</given-names></name><name><surname>Ji</surname><given-names>H</given-names></name><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>McCrea</surname><given-names>PD</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><year>2013</year><article-title>Lung epithelial branching program antagonizes alveolar differentiation</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>110</volume><fpage>18042</fpage><lpage>18051</lpage><pub-id pub-id-type="doi">10.1073/pnas.1311760110</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Acciani</surname><given-names>T</given-names></name><name><surname>Le Cras</surname><given-names>T</given-names></name><name><surname>Lutzko</surname><given-names>C</given-names></name><name><surname>Perl</surname><given-names>AK</given-names></name></person-group><year>2012</year><article-title>Dynamic regulation of platelet-derived growth factor receptor α expression in alveolar fibroblasts during realveolarization</article-title><source>American Journal of Respiratory Cell and Molecular Biology</source><volume>47</volume><fpage>517</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2012-0030OC</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Khaleel</surname><given-names>SS</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>CH</given-names></name></person-group><year>2014a</year><article-title>Software for pre-processing illumina next-generation sequencing short read sequences</article-title><source>Source Code for Biology and Medicine</source><volume>9</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1186/1751-0473-9-8</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YJ</given-names></name><name><surname>Finkbeiner</surname><given-names>SR</given-names></name><name><surname>Weinblatt</surname><given-names>D</given-names></name><name><surname>Emmett</surname><given-names>MJ</given-names></name><name><surname>Tameire</surname><given-names>F</given-names></name><name><surname>Yousefi</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Maehr</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Shemer</surname><given-names>R</given-names></name><name><surname>Dor</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Spence</surname><given-names>JR</given-names></name><name><surname>Stanger</surname><given-names>BZ</given-names></name></person-group><year>2014b</year><article-title>De novo formationof insulin-producing ‘Neo-b cell Islets’ from intestinal crypts</article-title><source>Cell Reports</source><volume>6</volume><fpage>1046</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.02.013</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Amour</surname><given-names>KA</given-names></name><name><surname>Agulnick</surname><given-names>AD</given-names></name><name><surname>Eliazer</surname><given-names>S</given-names></name><name><surname>Kelly</surname><given-names>OG</given-names></name><name><surname>Kroon</surname><given-names>E</given-names></name><name><surname>Baetge</surname><given-names>EE</given-names></name></person-group><year>2005</year><article-title>Efficient differentiation of human embryonic stem cells to definitive endoderm</article-title><source>Nature Biotechnology</source><volume>23</volume><fpage>1534</fpage><lpage>1541</lpage><pub-id pub-id-type="doi">10.1038/nbt1163</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Amour</surname><given-names>KA</given-names></name><name><surname>Bang</surname><given-names>AG</given-names></name><name><surname>Eliazer</surname><given-names>S</given-names></name><name><surname>Kelly</surname><given-names>OG</given-names></name><name><surname>Agulnick</surname><given-names>AD</given-names></name><name><surname>Smart</surname><given-names>NG</given-names></name><name><surname>Moorman</surname><given-names>MA</given-names></name><name><surname>Kroon</surname><given-names>E</given-names></name><name><surname>Carpenter</surname><given-names>MK</given-names></name><name><surname>Baetge</surname><given-names>EE</given-names></name></person-group><year>2006</year><article-title>Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells</article-title><source>Nature Biotechnology</source><volume>24</volume><fpage>1392</fpage><lpage>1401</lpage><pub-id pub-id-type="doi">10.1038/nbt1259</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLaForest</surname><given-names>A</given-names></name><name><surname>Nagaoka</surname><given-names>M</given-names></name><name><surname>Si-Tayeb</surname><given-names>K</given-names></name><name><surname>Noto</surname><given-names>FK</given-names></name><name><surname>Konopka</surname><given-names>G</given-names></name><name><surname>Battle</surname><given-names>MA</given-names></name><name><surname>Duncan</surname><given-names>SA</given-names></name></person-group><year>2011</year><article-title>HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells</article-title><source>Development</source><volume>138</volume><fpage>4143</fpage><lpage>4153</lpage><pub-id pub-id-type="doi">10.1242/dev.062547</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname><given-names>TJ</given-names></name><name><surname>Brownfield</surname><given-names>DG</given-names></name><name><surname>Krasnow</surname><given-names>MA</given-names></name></person-group><year>2014</year><article-title>Alveolar progenitor and stem cells in lung development, renewal and cancer</article-title><source>Nature</source><volume>507</volume><fpage>190</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1038/nature12930</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domyan</surname><given-names>ET</given-names></name><name><surname>Ferretti</surname><given-names>E</given-names></name><name><surname>Throckmorton</surname><given-names>K</given-names></name><name><surname>Mishina</surname><given-names>Y</given-names></name><name><surname>Nicolis</surname><given-names>SK</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name></person-group><year>2011</year><article-title>Signaling through BMP receptors promotes respiratory identity in the foregut via repression of Sox2</article-title><source>Development</source><volume>138</volume><fpage>971</fpage><lpage>981</lpage><pub-id pub-id-type="doi">10.1242/dev.053694</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisen</surname><given-names>MB</given-names></name><name><surname>Spellman</surname><given-names>PT</given-names></name><name><surname>Brown</surname><given-names>PO</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name></person-group><year>1998</year><article-title>Cluster analysis and display of genome-wide expression patterns</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>95</volume><fpage>14863</fpage><lpage>14868</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.25.14863</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>MJ</given-names></name><name><surname>Van Winkle</surname><given-names>LS</given-names></name><name><surname>Fanucchi</surname><given-names>MV</given-names></name><name><surname>Plopper</surname><given-names>CG</given-names></name></person-group><year>2001</year><article-title>Cellular and molecular characteristics of basal cells in airway epithelium</article-title><source>Experimental Lung Research</source><volume>27</volume><fpage>401</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1080/019021401300317125</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firth</surname><given-names>AL</given-names></name><name><surname>Dargitz</surname><given-names>CT</given-names></name><name><surname>Qualls</surname><given-names>SJ</given-names></name><name><surname>Menon</surname><given-names>T</given-names></name><name><surname>Wright</surname><given-names>R</given-names></name><name><surname>Singer</surname><given-names>O</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name><name><surname>Khanna</surname><given-names>A</given-names></name><name><surname>Verma</surname><given-names>IM</given-names></name></person-group><year>2014</year><article-title>Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>111</volume><fpage>E1723</fpage><lpage>E1730</lpage><pub-id pub-id-type="doi">10.1073/pnas.1403470111</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franzdóttir</surname><given-names>SR</given-names></name><name><surname>Axelsson</surname><given-names>IT</given-names></name><name><surname>Arason</surname><given-names>AJ</given-names></name><name><surname>Baldursson</surname><given-names>O</given-names></name><name><surname>Gudjonsson</surname><given-names>T</given-names></name><name><surname>Magnusson</surname><given-names>MK</given-names></name></person-group><year>2010</year><article-title>Airway branching morphogenesis in three dimensional culture</article-title><source>Respiratory Research</source><volume>11</volume><fpage>162</fpage><pub-id pub-id-type="doi">10.1186/1465-9921-11-162</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaedi</surname><given-names>M</given-names></name><name><surname>Calle</surname><given-names>EA</given-names></name><name><surname>Mendez</surname><given-names>JJ</given-names></name><name><surname>Gard</surname><given-names>AL</given-names></name><name><surname>Balestrini</surname><given-names>J</given-names></name><name><surname>Booth</surname><given-names>A</given-names></name><name><surname>Bove</surname><given-names>PF</given-names></name><name><surname>Gui</surname><given-names>L</given-names></name><name><surname>White</surname><given-names>ES</given-names></name><name><surname>Niklason</surname><given-names>LE</given-names></name></person-group><year>2013</year><article-title>Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix</article-title><source>The Journal of Clinical Investigation</source><volume>123</volume><fpage>4950</fpage><lpage>4962</lpage><pub-id pub-id-type="doi">10.1172/JCI68793</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>MD</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Nostro</surname><given-names>MC</given-names></name><name><surname>d'Souza</surname><given-names>SL</given-names></name><name><surname>Schaniel</surname><given-names>C</given-names></name><name><surname>Lemischka</surname><given-names>IR</given-names></name><name><surname>Gouon-Evans</surname><given-names>V</given-names></name><name><surname>Keller</surname><given-names>G</given-names></name><name><surname>Snoeck</surname><given-names>HW</given-names></name></person-group><year>2011</year><article-title>Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells</article-title><source>Nature Biotechnology</source><volume>29</volume><fpage>267</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1038/nbt.1788</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havrilak</surname><given-names>JA</given-names></name><name><surname>Shannon</surname><given-names>JM</given-names></name></person-group><year>2015</year><article-title>Branching of lung epithelium in vitro occurs in the absence of endothelial cells</article-title><source>Developmental Dynamics</source><pub-id pub-id-type="doi">10.1002/dvdy.24251</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hebrok</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Melton</surname><given-names>DA</given-names></name></person-group><year>1998</year><article-title>Notochord repression of endodermal Sonic hedgehog permits pancreas development</article-title><source>Genes &amp; Development</source><volume>12</volume><fpage>1705</fpage><lpage>1713</lpage><pub-id pub-id-type="doi">10.1101/gad.12.11.1705</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinz</surname><given-names>B</given-names></name><name><surname>Phan</surname><given-names>SH</given-names></name><name><surname>Thannickal</surname><given-names>VJ</given-names></name><name><surname>Galli</surname><given-names>A</given-names></name><name><surname>Bochaton-Piallat</surname><given-names>M-L</given-names></name><name><surname>Gabbiani</surname><given-names>G</given-names></name></person-group><year>2007</year><article-title>The myofibroblast: one function, multiple origins</article-title><source>The American Journal of Pathology</source><volume>170</volume><fpage>1807</fpage><lpage>1816</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2007.070112</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hrvatin</surname><given-names>S</given-names></name><name><surname>O'Donnell</surname><given-names>CW</given-names></name><name><surname>Deng</surname><given-names>F</given-names></name><name><surname>Millman</surname><given-names>JR</given-names></name><name><surname>Pagliuca</surname><given-names>FW</given-names></name><name><surname>DiIorio</surname><given-names>P</given-names></name><name><surname>Rezania</surname><given-names>A</given-names></name><name><surname>Gifford</surname><given-names>DK</given-names></name><name><surname>Melton</surname><given-names>DA</given-names></name></person-group><year>2014</year><article-title>Differentiated human stem cells resemble fetal, not adult, β cells</article-title><source>Proceedings of the National Academy of Sciences USA</source><volume>111</volume><fpage>3038</fpage><lpage>3043</lpage><pub-id pub-id-type="doi">10.1073/pnas.1400709111</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>SX</given-names></name><name><surname>Islam</surname><given-names>MN</given-names></name><name><surname>O'Neill</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>YG</given-names></name><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Mumau</surname><given-names>M</given-names></name><name><surname>Green</surname><given-names>MD</given-names></name><name><surname>Vunjak-Novakovic</surname><given-names>G</given-names></name><name><surname>Bhattacharya</surname><given-names>J</given-names></name><name><surname>Snoeck</surname><given-names>HW</given-names></name></person-group><year>2013</year><article-title>Efficient generation of lung and airway epithelial cells from human pluripotent stem cells</article-title><source>Nature Biotechnology</source><volume>32</volume><fpage>84</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1038/nbt.2754</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name></person-group><year>2004</year><article-title>Cluster analysis for gene expression data: a survey</article-title><source>IEEE Transactions on Knowledge and Data Engineering</source><volume>16</volume><fpage>1370</fpage><lpage>1386</lpage><pub-id pub-id-type="doi">10.1109/TKDE.2004.68</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadzik</surname><given-names>RS</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><year>2012</year><article-title>Directing lung endoderm differentiation in pluripotent stem cells</article-title><source>Cell Stem Cell</source><volume>10</volume><fpage>355</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2012.03.013</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HY</given-names></name><name><surname>Nelson</surname><given-names>CM</given-names></name></person-group><year>2012</year><article-title>Extracellular matrix and cytoskeletal dynamics during branching morphogenesis</article-title><source>Organogenesis</source><volume>8</volume><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.4161/org.19813</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>S</given-names></name><name><surname>Hara</surname><given-names>Y</given-names></name><name><surname>Pineau</surname><given-names>T</given-names></name><name><surname>Fernandez-Salguero</surname><given-names>P</given-names></name><name><surname>Fox</surname><given-names>CH</given-names></name><name><surname>Ward</surname><given-names>JM</given-names></name><name><surname>Gonzalez</surname><given-names>FJ</given-names></name></person-group><year>1996</year><article-title>The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary</article-title><source>Genes &amp; Development</source><volume>10</volume><fpage>60</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1101/gad.10.1.60</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroon</surname><given-names>E</given-names></name><name><surname>Martinson</surname><given-names>LA</given-names></name><name><surname>Kadoya</surname><given-names>K</given-names></name><name><surname>Bang</surname><given-names>AG</given-names></name><name><surname>Kelly</surname><given-names>OG</given-names></name><name><surname>Eliazer</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>H</given-names></name><name><surname>Richardson</surname><given-names>M</given-names></name><name><surname>Smart</surname><given-names>NG</given-names></name><name><surname>Cunningham</surname><given-names>J</given-names></name><name><surname>Agulnick</surname><given-names>AD</given-names></name><name><surname>D'Amour</surname><given-names>KA</given-names></name><name><surname>Carpenter</surname><given-names>MK</given-names></name><name><surname>Baetge</surname><given-names>EE</given-names></name></person-group><year>2008</year><article-title>Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo</article-title><source>Nature Biotechnology</source><volume>26</volume><fpage>443</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1038/nbt1393</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusakabe</surname><given-names>T</given-names></name><name><surname>Kawaguchi</surname><given-names>A</given-names></name><name><surname>Hoshi</surname><given-names>N</given-names></name><name><surname>Kawaguchi</surname><given-names>R</given-names></name><name><surname>Hoshi</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>S</given-names></name></person-group><year>2006</year><article-title>Thyroid-specific enhancer-binding protein/NKX2.1 is required for the maintenance of ordered architecture and function of the differentiated thyroid</article-title><source>Molecular Endocrinology</source><volume>20</volume><fpage>1796</fpage><lpage>1809</lpage><pub-id pub-id-type="doi">10.1210/me.2005-0327</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lancaster</surname><given-names>MA</given-names></name><name><surname>Renner</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>CA</given-names></name><name><surname>Wenzel</surname><given-names>D</given-names></name><name><surname>Bicknell</surname><given-names>LS</given-names></name><name><surname>Hurles</surname><given-names>ME</given-names></name><name><surname>Homfray</surname><given-names>T</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name><name><surname>Jackson</surname><given-names>AP</given-names></name><name><surname>Knoblich</surname><given-names>JA</given-names></name></person-group><year>2013</year><article-title>Cerebral organoids model human brain development and microcephaly</article-title><source>Nature</source><volume>501</volume><fpage>373</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1038/nature12517</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pop</surname><given-names>M</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year>2009</year><article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title><source>Genome Biology</source><volume>10</volume><fpage>R25</fpage><pub-id pub-id-type="doi">10.1186/gb-2009-10-3-r25</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leslie</surname><given-names>KO</given-names></name><name><surname>Mitchell</surname><given-names>JJ</given-names></name><name><surname>Woodcock-Mitchell</surname><given-names>JL</given-names></name><name><surname>Low</surname><given-names>RB</given-names></name></person-group><year>1990</year><article-title>Alpha smooth muscle actin expression in developing and adult human lung</article-title><source>Differentiation; Research in Biological Diversity</source><volume>44</volume><fpage>143</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1111/j.1432-0436.1990.tb00547.x</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>SC</given-names></name><name><surname>Litingtung</surname><given-names>Y</given-names></name><name><surname>Chiang</surname><given-names>C</given-names></name></person-group><year>2004</year><article-title>Sonic hedgehog signaling regulates Gli3 processing, mesenchymal proliferation, and differentiation during mouse lung organogenesis</article-title><source>Developmental Biology</source><volume>270</volume><fpage>214</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2004.03.009</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname><given-names>KM</given-names></name><name><surname>Ang</surname><given-names>LT</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Ang</surname><given-names>J</given-names></name><name><surname>Auyeong</surname><given-names>JQ</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><name><surname>Choo</surname><given-names>SH</given-names></name><name><surname>Lim</surname><given-names>CY</given-names></name><name><surname>Nichane</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Noghabi</surname><given-names>MS</given-names></name><name><surname>Azzola</surname><given-names>L</given-names></name><name><surname>Ng</surname><given-names>ES</given-names></name><name><surname>Durruthy-Durruthy</surname><given-names>J</given-names></name><name><surname>Sebastiano</surname><given-names>V</given-names></name><name><surname>Poellinger</surname><given-names>L</given-names></name><name><surname>Elefanty</surname><given-names>AG</given-names></name><name><surname>Stanley</surname><given-names>EG</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Prabhakar</surname><given-names>S</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name><name><surname>Lim</surname><given-names>B</given-names></name></person-group><year>2014</year><article-title>Efficient endoderm induction from human pluripotent stem cells by logically directing signals controlling lineage bifurcations</article-title><source>Cell Stem Cell</source><volume>14</volume><fpage>237</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2013.12.007</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longmire</surname><given-names>TA</given-names></name><name><surname>Ikonomou</surname><given-names>L</given-names></name><name><surname>Hawkins</surname><given-names>F</given-names></name><name><surname>Christodoulou</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Jean</surname><given-names>JC</given-names></name><name><surname>Kwok</surname><given-names>LW</given-names></name><name><surname>Mou</surname><given-names>H</given-names></name><name><surname>Rajagopal</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>SS</given-names></name><name><surname>Dowton</surname><given-names>AA</given-names></name><name><surname>Serra</surname><given-names>M</given-names></name><name><surname>Weiss</surname><given-names>DJ</given-names></name><name><surname>Green</surname><given-names>MD</given-names></name><name><surname>Snoeck</surname><given-names>HW</given-names></name><name><surname>Ramirez</surname><given-names>MI</given-names></name><name><surname>Kotton</surname><given-names>DN</given-names></name></person-group><year>2012</year><article-title>Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells</article-title><source>Cell Stem Cell</source><volume>10</volume><fpage>398</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2012.01.019</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Low</surname><given-names>RB</given-names></name><name><surname>White</surname><given-names>SL</given-names></name></person-group><year>1998</year><article-title>Lung smooth muscle differentiation</article-title><source>The International Journal of Biochemistry &amp; Cell Biology</source><volume>30</volume><fpage>869</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1016/S1357-2725(98)00049-1</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansouri</surname><given-names>A</given-names></name><name><surname>Chowdhury</surname><given-names>K</given-names></name><name><surname>Gruss</surname><given-names>P</given-names></name></person-group><year>1998</year><article-title>Follicular cells of the thyroid gland require Pax8 gene function</article-title><source>Nature Genetics</source><volume>19</volume><fpage>87</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1038/ng0598-87</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCracken</surname><given-names>KW</given-names></name><name><surname>Catá</surname><given-names>EM</given-names></name><name><surname>Crawford</surname><given-names>CM</given-names></name><name><surname>Sinagoga</surname><given-names>KL</given-names></name><name><surname>Schumacher</surname><given-names>M</given-names></name><name><surname>Rockich</surname><given-names>BE</given-names></name><name><surname>Tsai</surname><given-names>YH</given-names></name><name><surname>Mayhew</surname><given-names>CN</given-names></name><name><surname>Spence</surname><given-names>JR</given-names></name><name><surname>Zavros</surname><given-names>Y</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name></person-group><year>2014</year><article-title>Modelling human development and disease in pluripotent stem-cell-derived gastric organoids</article-title><source>Nature</source><volume>516</volume><fpage>400</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1038/nature13863</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCracken</surname><given-names>KW</given-names></name><name><surname>Howell</surname><given-names>JC</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name><name><surname>Spence</surname><given-names>JR</given-names></name></person-group><year>2011</year><article-title>Generating human intestinal tissue from pluripotent stem cells in vitro</article-title><source>Nature Protocols</source><volume>6</volume><fpage>1920</fpage><lpage>1928</lpage><pub-id pub-id-type="doi">10.1038/nprot.2011.410</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>JS</given-names></name><name><surname>Howden</surname><given-names>SE</given-names></name><name><surname>Wallace</surname><given-names>KA</given-names></name><name><surname>Verhoeven</surname><given-names>AD</given-names></name><name><surname>Wright</surname><given-names>LS</given-names></name><name><surname>Capowski</surname><given-names>EE</given-names></name><name><surname>Pinilla</surname><given-names>I</given-names></name><name><surname>Martin</surname><given-names>JM</given-names></name><name><surname>Tian</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>R</given-names></name><name><surname>Pattnaik</surname><given-names>B</given-names></name><name><surname>Thomson</surname><given-names>JA</given-names></name><name><surname>Gamm</surname><given-names>DM</given-names></name></person-group><year>2011</year><article-title>Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment</article-title><source>Stem Cells</source><volume>29</volume><fpage>1206</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1002/stem.674</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>H</given-names></name><name><surname>Danilenko</surname><given-names>DM</given-names></name><name><surname>Scully</surname><given-names>SA</given-names></name><name><surname>Bolon</surname><given-names>B</given-names></name><name><surname>Ring</surname><given-names>BD</given-names></name><name><surname>Tarpley</surname><given-names>JE</given-names></name><name><surname>DeRose</surname><given-names>M</given-names></name><name><surname>Simonet</surname><given-names>WS</given-names></name></person-group><year>1998</year><article-title>Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to <italic>Drosophila</italic> branchless</article-title><source>Genes &amp; Development</source><volume>12</volume><fpage>3156</fpage><lpage>3161</lpage><pub-id pub-id-type="doi">10.1101/gad.12.20.3156</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monaghan</surname><given-names>AP</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Grau</surname><given-names>E</given-names></name><name><surname>Schütz</surname><given-names>G</given-names></name></person-group><year>1993</year><article-title>Postimplantation expression patterns indicate a role for the mouse forkhead/HNF-3 alpha, beta and gamma genes in determination of the definitive endoderm, chordamesoderm and neuroectoderm</article-title><source>Development</source><volume>119</volume><fpage>567</fpage><lpage>578</lpage></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>KA</given-names></name><name><surname>Polte</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>B</given-names></name><name><surname>Alsberg</surname><given-names>E</given-names></name><name><surname>Sunday</surname><given-names>ME</given-names></name><name><surname>Ingber</surname><given-names>DE</given-names></name></person-group><year>2005</year><article-title>Control of basement membrane remodeling and epithelial branching morphogenesis in embryonic lung by Rho and cytoskeletal tension</article-title><source>Developmental Dynamics</source><volume>232</volume><fpage>268</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1002/dvdy.20237</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrisey</surname><given-names>EE</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group><year>2010</year><article-title>Preparing for the first breath: genetic and cellular mechanisms in lung development</article-title><source>Developmental Cell</source><volume>18</volume><fpage>8</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.12.010</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motoyama</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Mo</surname><given-names>R</given-names></name><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Post</surname><given-names>M</given-names></name><name><surname>Hui</surname><given-names>CC</given-names></name></person-group><year>1998</year><article-title>Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus</article-title><source>Nature Genetics</source><volume>20</volume><fpage>54</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/1711</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mou</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Sherwood</surname><given-names>R</given-names></name><name><surname>Ahfeldt</surname><given-names>T</given-names></name><name><surname>Lapey</surname><given-names>A</given-names></name><name><surname>Wain</surname><given-names>J</given-names></name><name><surname>Sicilian</surname><given-names>L</given-names></name><name><surname>Izvolsky</surname><given-names>K</given-names></name><name><surname>Musunuru</surname><given-names>K</given-names></name><name><surname>Cowan</surname><given-names>C</given-names></name><name><surname>Rajagopal</surname><given-names>J</given-names></name></person-group><year>2012</year><article-title>Generation of multipotent lung and airway progenitors from mouse ESCs and Patient-specific Cystic Fibrosis iPSCs</article-title><source>Cell Stem Cell</source><volume>10</volume><fpage>385</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2012.01.018</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Kawanami</surname><given-names>O</given-names></name><name><surname>Jin</surname><given-names>E</given-names></name><name><surname>Ghazizadeh</surname><given-names>M</given-names></name><name><surname>Honda</surname><given-names>M</given-names></name><name><surname>Asano</surname><given-names>G</given-names></name><name><surname>Horiba</surname><given-names>K</given-names></name><name><surname>Ferrans</surname><given-names>VJ</given-names></name></person-group><year>1998</year><article-title>Immunohistochemical and ultrastructural studies of basal cells, Clara cells and bronchiolar cuboidal cells in normal human airways</article-title><source>Pathology International</source><volume>48</volume><fpage>944</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1827.1998.tb03865.x</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Ando</surname><given-names>S</given-names></name><name><surname>Takata</surname><given-names>N</given-names></name><name><surname>Kawada</surname><given-names>M</given-names></name><name><surname>Muguruma</surname><given-names>K</given-names></name><name><surname>Sekiguchi</surname><given-names>K</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name><name><surname>Yonemura</surname><given-names>S</given-names></name><name><surname>Eiraku</surname><given-names>M</given-names></name><name><surname>Sasai</surname><given-names>Y</given-names></name></person-group><year>2012</year><article-title>Self-formation of optic cups and storable stratified neural retina from human ESCs</article-title><source>Cell Stem Cell</source><volume>10</volume><fpage>771</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2012.05.009</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narumi</surname><given-names>S</given-names></name><name><surname>Araki</surname><given-names>S</given-names></name><name><surname>Hori</surname><given-names>N</given-names></name><name><surname>Muroya</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Asakura</surname><given-names>Y</given-names></name><name><surname>Adachi</surname><given-names>M</given-names></name><name><surname>Hasegawa</surname><given-names>T</given-names></name></person-group><year>2012</year><article-title>Functional characterization of four novel PAX8 mutations causing congenital hypothyroidism: new evidence for haploinsufficiency as a disease mechanism</article-title><source>European Journal of Endocrinology</source><volume>167</volume><fpage>625</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1530/EJE-12-0410</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyeng</surname><given-names>P</given-names></name><name><surname>Norgaard</surname><given-names>GA</given-names></name><name><surname>Kobberup</surname><given-names>S</given-names></name><name><surname>Jensen</surname><given-names>J</given-names></name></person-group><year>2008</year><article-title>FGF10 maintains distal lung bud epithelium and excessive signaling leads to progenitor state arrest, distalization, and goblet cell metaplasia</article-title><source>BMC Developmental Biology</source><volume>8</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.1186/1471-213X-8-2</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okubo</surname><given-names>T</given-names></name></person-group><year>2005</year><article-title>Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation</article-title><source>Development</source><volume>132</volume><fpage>1363</fpage><lpage>1374</lpage><pub-id pub-id-type="doi">10.1242/dev.01678</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasov</surname><given-names>L</given-names></name><name><surname>Nagy</surname><given-names>M</given-names></name><name><surname>Rudolph</surname><given-names>DD</given-names></name><name><surname>Glaser</surname><given-names>T</given-names></name></person-group><year>2012</year><article-title>Math5 (Atoh7) gene dosage limits retinal ganglion cell genesis</article-title><source>Neuroreport</source><volume>23</volume><fpage>631</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1097/WNR.0b013e328355f260</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramasamy</surname><given-names>SK</given-names></name><name><surname>Mailleux</surname><given-names>AA</given-names></name><name><surname>Gupte</surname><given-names>VV</given-names></name><name><surname>Mata</surname><given-names>F</given-names></name><name><surname>Sala</surname><given-names>FG</given-names></name><name><surname>Veltmaat</surname><given-names>JM</given-names></name><name><surname>Del Moral</surname><given-names>PM</given-names></name><name><surname>De Langhe</surname><given-names>S</given-names></name><name><surname>Parsa</surname><given-names>S</given-names></name><name><surname>Kelly</surname><given-names>LK</given-names></name></person-group><year>2007</year><article-title>Fgf10 dosage is critical for the amplification of epithelial cell progenitors and for the formation of multiple mesenchymal lineages during lung development</article-title><source>Developmental Biology</source><volume>307</volume><fpage>237</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2007.04.033</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rankin</surname><given-names>SA</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name></person-group><year>2014</year><article-title>Gene regulatory networks governing lung specification</article-title><source>Journal of Cellular Biochemistry</source><volume>115</volume><fpage>1343</fpage><lpage>1350</lpage><pub-id pub-id-type="doi">10.1002/jcb.24810</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawlins</surname><given-names>EL</given-names></name><name><surname>Clark</surname><given-names>CP</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group><year>2009</year><article-title>The Id2+ distal tip lung epithelium contains individual multipotent embryonic progenitor cells</article-title><source>Development</source><volume>136</volume><fpage>3741</fpage><lpage>3745</lpage><pub-id pub-id-type="doi">10.1242/dev.037317</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ringnér</surname><given-names>M</given-names></name></person-group><year>2008</year><article-title>What is principal component analysis?</article-title><source>Nature Biotechnology</source><volume>26</volume><fpage>303</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1038/nbt0308-303</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rock</surname><given-names>JR</given-names></name><name><surname>Onaitis</surname><given-names>MW</given-names></name><name><surname>Rawlins</surname><given-names>EL</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Clark</surname><given-names>CP</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group><year>2009</year><article-title>Basal cells as stem cells of the mouse trachea and human airway epithelium</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>106</volume><fpage>12771</fpage><lpage>12775</lpage><pub-id pub-id-type="doi">10.1073/pnas.0906850106</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rockich</surname><given-names>BE</given-names></name><name><surname>Hrycaj</surname><given-names>SM</given-names></name><name><surname>Shih</surname><given-names>HP</given-names></name><name><surname>Nagy</surname><given-names>MS</given-names></name><name><surname>Ferguson</surname><given-names>MA</given-names></name><name><surname>Kopp</surname><given-names>JL</given-names></name><name><surname>Sander</surname><given-names>M</given-names></name><name><surname>Wellik</surname><given-names>DM</given-names></name><name><surname>Spence</surname><given-names>JR</given-names></name></person-group><year>2013</year><article-title>Sox9 plays multiple roles in the lung epithelium during branching morphogenesis</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>110</volume><fpage>E4456</fpage><lpage>E4464</lpage><pub-id pub-id-type="doi">10.1073/pnas.1311847110</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>G</given-names></name><name><surname>Müller</surname><given-names>G</given-names></name></person-group><year>1991</year><article-title>Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids</article-title><source>Journal of Lipid Research</source><volume>32</volume><fpage>1539</fpage><lpage>1570</lpage></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serls</surname><given-names>AE</given-names></name><name><surname>Doherty</surname><given-names>S</given-names></name><name><surname>Parvatiyar</surname><given-names>P</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name><name><surname>Deutsch</surname><given-names>GH</given-names></name></person-group><year>2004</year><article-title>Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung</article-title><source>Development</source><volume>132</volume><fpage>35</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1242/dev.01570</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Si-Tayeb</surname><given-names>K</given-names></name><name><surname>Noto</surname><given-names>FK</given-names></name><name><surname>Nagaoka</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Battle</surname><given-names>MA</given-names></name><name><surname>Duris</surname><given-names>C</given-names></name><name><surname>North</surname><given-names>PE</given-names></name><name><surname>Dalton</surname><given-names>S</given-names></name><name><surname>Duncan</surname><given-names>SA</given-names></name></person-group><year>2009</year><article-title>Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells</article-title><source>Hepatology</source><volume>51</volume><fpage>297</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1002/hep.23354</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spence</surname><given-names>JR</given-names></name><name><surname>Lange</surname><given-names>AW</given-names></name><name><surname>Lin</surname><given-names>SC</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Lowy</surname><given-names>AM</given-names></name><name><surname>Kim</surname><given-names>I</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name></person-group><year>2009</year><article-title>Sox17 Regulates Organ Lineage Segregation of Ventral Foregut Progenitor Cells</article-title><source>Developmental Cell</source><volume>17</volume><fpage>62</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.05.012</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spence</surname><given-names>JR</given-names></name><name><surname>Mayhew</surname><given-names>CN</given-names></name><name><surname>Rankin</surname><given-names>SA</given-names></name><name><surname>Kuhar</surname><given-names>MF</given-names></name><name><surname>Vallance</surname><given-names>JE</given-names></name><name><surname>Tolle</surname><given-names>K</given-names></name><name><surname>Hoskins</surname><given-names>EE</given-names></name><name><surname>Kalinichenko</surname><given-names>VV</given-names></name><name><surname>Wells</surname><given-names>SI</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name><name><surname>Shroyer</surname><given-names>NF</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name></person-group><year>2011</year><article-title>Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro</article-title><source>Nature</source><volume>470</volume><fpage>105</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1038/nature09691</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stahlman</surname><given-names>MT</given-names></name><name><surname>Gray</surname><given-names>MP</given-names></name><name><surname>Falconieri</surname><given-names>MW</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name><name><surname>Weaver</surname><given-names>TE</given-names></name></person-group><year>2000</year><article-title>Lamellar body formation in normal and surfactant protein B-deficient fetal mice</article-title><source>Laboratory Investigation; a Journal of Technical Methods and Pathology</source><volume>80</volume><fpage>395</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1038/labinvest.3780044</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stott</surname><given-names>SR</given-names></name><name><surname>Metzakopian</surname><given-names>E</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Hen</surname><given-names>R</given-names></name><name><surname>Ang</surname><given-names>SL</given-names></name></person-group><year>2013</year><article-title>Foxa1 and Foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>8022</fpage><lpage>8034</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4774-12.2013</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>R</given-names></name><name><surname>Shimodaira</surname><given-names>H</given-names></name></person-group><year>2006</year><article-title>Pvclust: an R package for assessing the uncertainty in hierarchical clustering</article-title><source>Bioinformatics</source><volume>22</volume><fpage>1540</fpage><lpage>1542</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btl117</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takebe</surname><given-names>T</given-names></name><name><surname>Sekine</surname><given-names>K</given-names></name><name><surname>Enomura</surname><given-names>M</given-names></name><name><surname>Koike</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Ogaeri</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>RR</given-names></name><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>YW</given-names></name><name><surname>Koike</surname><given-names>N</given-names></name><name><surname>Aoyama</surname><given-names>S</given-names></name><name><surname>Adachi</surname><given-names>Y</given-names></name><name><surname>Taniguchi</surname><given-names>H</given-names></name></person-group><year>2013</year><article-title>Vascularized and functional human liver from an iPSC-derived organ bud transplant</article-title><source>Nature</source><volume>499</volume><fpage>481</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1038/nature12271</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Roberts</surname><given-names>A</given-names></name><name><surname>Goff</surname><given-names>L</given-names></name><name><surname>Pertea</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Kelley</surname><given-names>DR</given-names></name><name><surname>Pimentel</surname><given-names>H</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name><name><surname>Rinn</surname><given-names>JL</given-names></name><name><surname>Pachter</surname><given-names>L</given-names></name></person-group><year>2012</year><article-title>Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks</article-title><source>Nature Protocols</source><volume>7</volume><fpage>562</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.016</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treutlein</surname><given-names>B</given-names></name><name><surname>Brownfield</surname><given-names>DG</given-names></name><name><surname>Wu</surname><given-names>AR</given-names></name><name><surname>Neff</surname><given-names>NF</given-names></name><name><surname>Mantalas</surname><given-names>GL</given-names></name><name><surname>Espinoza</surname><given-names>FH</given-names></name><name><surname>Desai</surname><given-names>TJ</given-names></name><name><surname>Krasnow</surname><given-names>MA</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name></person-group><year>2014</year><article-title>Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq</article-title><source>Nature</source><volume>509</volume><fpage>371</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1038/nature13173</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilain</surname><given-names>C</given-names></name><name><surname>Rydlewski</surname><given-names>C</given-names></name><name><surname>Duprez</surname><given-names>L</given-names></name><name><surname>Heinrichs</surname><given-names>C</given-names></name><name><surname>Abramowicz</surname><given-names>M</given-names></name><name><surname>Malvaux</surname><given-names>P</given-names></name><name><surname>Renneboog</surname><given-names>B</given-names></name><name><surname>Parma</surname><given-names>J</given-names></name><name><surname>Costagliola</surname><given-names>S</given-names></name><name><surname>Vassart</surname><given-names>G</given-names></name></person-group><year>2001</year><article-title>Autosomal dominant transmission of congenital thyroid hypoplasia due to loss-of-function mutation of PAX8</article-title><source>The Journal of Clinical Endocrinology and Metabolism</source><volume>86</volume><fpage>234</fpage><lpage>238</lpage></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volckaert</surname><given-names>T</given-names></name><name><surname>Campbell</surname><given-names>A</given-names></name><name><surname>Dill</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Minoo</surname><given-names>P</given-names></name><name><surname>De Langhe</surname><given-names>S</given-names></name></person-group><year>2013</year><article-title>Localized Fgf10 expression is not required for lung branching morphogenesis but prevents differentiation of epithelial progenitors</article-title><source>Development</source><volume>140</volume><fpage>3731</fpage><lpage>3742</lpage><pub-id pub-id-type="doi">10.1242/dev.096560</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Wert</surname><given-names>SE</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name></person-group><year>2013</year><article-title>CDC42 is required for structural patterning of the lung during development</article-title><source>Developmental Biology</source><volume>374</volume><fpage>46</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2012.11.030</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>CL</given-names></name><name><surname>Mahe</surname><given-names>MM</given-names></name><name><surname>Múnera</surname><given-names>J</given-names></name><name><surname>Howell</surname><given-names>JC</given-names></name><name><surname>Sundaram</surname><given-names>N</given-names></name><name><surname>Poling</surname><given-names>HM</given-names></name><name><surname>Schweitzer</surname><given-names>JI</given-names></name><name><surname>Vallance</surname><given-names>JE</given-names></name><name><surname>Mayhew</surname><given-names>CN</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Grabowski</surname><given-names>G</given-names></name><name><surname>Finkbeiner</surname><given-names>SR</given-names></name><name><surname>Spence</surname><given-names>JR</given-names></name><name><surname>Shroyer</surname><given-names>NF</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name><name><surname>Helmrath</surname><given-names>MA</given-names></name></person-group><year>2014</year><article-title>An in vivo model of human small intestine using pluripotent stem cells</article-title><source>Nature Medicine</source><volume>20</volume><fpage>1310</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1038/nm.3737</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>M</given-names></name><name><surname>Dunn</surname><given-names>NR</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group><year>2000</year><article-title>Bmp4 and Fgf10 play opposing roles during lung bud morphogenesis</article-title><source>Development</source><volume>127</volume><fpage>2695</fpage><lpage>2704</lpage></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>TE</given-names></name><name><surname>Na</surname><given-names>CL</given-names></name><name><surname>Stahlman</surname><given-names>M</given-names></name></person-group><year>2002</year><article-title>Biogenesis of lamellar bodies, lysosome-related organelles involved in storage and secretion of pulmonary surfactant</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>13</volume><fpage>263</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/S1084952102000551</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>JM</given-names></name><name><surname>Spence</surname><given-names>JR</given-names></name></person-group><year>2014</year><article-title>How to make an intestine</article-title><source>Development</source><volume>141</volume><fpage>752</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1242/dev.097386</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><year>2009</year><source>ggplot2: Elegant Graphics for Data Analysis</source><comment>Google Books</comment></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>AP</given-names></name><name><surname>Bear</surname><given-names>CE</given-names></name><name><surname>Chin</surname><given-names>S</given-names></name><name><surname>Pasceri</surname><given-names>P</given-names></name><name><surname>Thompson</surname><given-names>TO</given-names></name><name><surname>Huan</surname><given-names>LJ</given-names></name><name><surname>Ratjen</surname><given-names>F</given-names></name><name><surname>Ellis</surname><given-names>J</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name></person-group><year>2012</year><article-title>Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein</article-title><source>Nature Biotechnology</source><volume>30</volume><fpage>876</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1038/nbt.2328</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>X</given-names></name><name><surname>Ramakrishnan</surname><given-names>S</given-names></name><name><surname>Anderson</surname><given-names>E</given-names></name><name><surname>Taylor</surname><given-names>M</given-names></name><name><surname>Zimmermann</surname><given-names>EM</given-names></name><name><surname>Spence</surname><given-names>JR</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Greenson</surname><given-names>JK</given-names></name><name><surname>Shah</surname><given-names>YM</given-names></name></person-group><year>2013</year><article-title>Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice</article-title><source>Gastroenterology</source><volume>145</volume><fpage>831</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2013.07.010</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Kimura</surname><given-names>S</given-names></name><name><surname>Engelhardt</surname><given-names>RT</given-names></name><name><surname>Smith</surname><given-names>BR</given-names></name><name><surname>Minoo</surname><given-names>P</given-names></name></person-group><year>2000</year><article-title>Inhibition of distal lung morphogenesis inNkx2.1(−/−) embryos</article-title><source>Developmental Dynamics</source><volume>217</volume><fpage>180</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0177(200002)217:2&lt;180::AID-DVDY5&gt;3.0.CO;2-3</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Teng</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year>2010</year><article-title>Expression of SHH signaling pathway components in the developing human lung</article-title><source>Histochemistry and Cell Biology</source><volume>134</volume><fpage>327</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1007/s00418-010-0738-2</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.05098.028</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Rossant</surname><given-names>Janet</given-names></name><role>Reviewing editor</role><aff><institution>University of Toronto</institution>, <country>Canada</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see <ext-link ext-link-type="uri" xlink:href="http://elifesciences.org/review-process">review process</ext-link>). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.</p></boxed-text><p>Thank you for sending your work entitled “In vitro generation of human pluripotent stem cell derived lung organoids” for consideration at <italic>eLife</italic>. Your article has been favorably evaluated by Janet Rossant (Senior editor and Reviewing editor) and 2 reviewers.</p><p>The Reviewing editor and the reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.</p><p>In this study, the authors describe a systematically delineated 3D protocol to generate human lung organoids from human pluripotent stem cells. HLOs possess organized proximal airway structures with apparently multiple differentiated epithelial cell types, as well as smooth muscle cells. There was enthusiasm for the overall concept and the potential of the system to be used to model lung differentiation, homeostasis and disease in vitro. This work should be of interest to the readership of <italic>eLife</italic>. However, there were concerns raised about the lack of in depth characterization of the different cell types generated and the lack of careful quantification of the extent of ordered differentiation in the system. For the paper to be reconsidered, we would ask you to address the various specific comments below, but to focus on careful characterization of the different lung cell types generated by extensive use of confocal imaging of co-staining with appropriate antibodies, such as FOXJ1, beta-tubulin, CC10, SCGB1A1, SCGB3A2, P63, Podoplanin, HOPX1, and more markers of SM compartment. It would also be important to provide more evidence that the organoids really regenerate at least partially the ordered branching seen in the lung- such that you could define a bronchioalveolar duct junction (BADJ) with the proper smooth muscle configuration. Further definition of the cell types arising from the mesenchyme would also be useful. Are there any cartilage cells or other types of cells such as lipofibroblasts, myofibroblasts, etc.</p><p>In addition, some quantification of the proportions of different cell types produced and comparison with other published lung differentiation protocols is required. We recognize that functional assessment of the cell types produced is difficult but use of EM identify lamellar bodies in type 2 cells would help.</p><p>Specific comments:</p><p><italic>Reviewer #1:</italic></p><p><xref ref-type="fig" rid="fig1">Figure 1</xref>: Foregut endoderm should be characterized by double positive for FOXA2+SOX2+. SOX2 single expression is not enough for anterior endoderm identification.</p><p><xref ref-type="fig" rid="fig2">Figure 2</xref>: especially <xref ref-type="fig" rid="fig2s1">Figure 2–figure supplement 1</xref>. In order to ensure NKX2.1+ are endoderm derived lung progenitors, co-staining with a battery of markers including FOXA2, SOX9, ID2, FOXP2 etc. are needed for comprehensive characterization.</p><p><xref ref-type="fig" rid="fig3">Figure 3</xref>: In the text, the authors claimed that most spheres co-expressed FOXA2, SOX2, and NKX2.1 protein. However, only single marker staining was shown. Double and triple staining is highly recommended.</p><p><xref ref-type="fig" rid="fig3">Figure 3E</xref>: the authors claimed that their lung organoids contains bipotent alveolar progenitor markers including NMYC, ID2, NKX2.1, SPC, and HOPX based on their q-PCR analysis. Those differentiated markers need to validated with double or triple co-staining.</p><p>In supplemental figures for <xref ref-type="fig" rid="fig3">Figure 3</xref>, the authors indicated that the majority of cells lose epithelial identity and become vimentin positive mesenchymal cells over time. It is also still possible that mesenchyme overgrew epithelium.</p><p><xref ref-type="fig" rid="fig4">Figure 4</xref>: Most differentiation marker staining is of poor quality and hard to interpret. For example, acetylated tubulin staining for ciliated cell is within the cell, rather than extend outside of the cell like cilia (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). CCSP is dot-like (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). P63 expression is a general epithelial stem cell markers, therefore co-staining of P63 with NKX2.1, FOXA2 and SOX2 are needed to ensure they are airway epithelial stem cells (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p><p><xref ref-type="fig" rid="fig5">Figure 5</xref>: Again, all markers need to be co-stained with NKX2.1 to ensure the lung progenitor identity. In both <xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="fig" rid="fig5">Figure 5</xref>, the authors need to provide quantitative data concerning the efficiency of airway and alveolar differentiation in their organoids.</p><p><italic>Reviewer #2</italic>:</p><p>1) HLOs have the ability to generate mature airway cells, but predominantly possess a bipotent alveolar progenitors. Does this protocol favors to proximal lung development? Does the length of time in 3D culture alter the ratio of proximal versus distal?</p><p>2) Increase in HH signaling leads to an increase in NKX2-1 expression in culture. Since HH signaling is received by mesenchymal cells, what is mediating its effect on NKX2-1?</p><p>3) Combined inhibition of endogenous FGF signaling with SU and activation of HH with SAG caused an additional increase in NKX2-1 expression (21 fold vs. 6.5 fold with SAG only). However, treating foregut cultures with SU along did not alter NKX2.1 expression. What is the explanation for the increase in NKX2-1 expression with the SU and HH combination?</p><p>4) What effect does HH has on SMC differentiation in culture?</p><p>5) Comparing experiments in <xref ref-type="fig" rid="fig2">Figure 2C</xref> versus 2D, it seems that NKX2-1 and PAX8 induction in these two experiments are quite different. Does the efficiency vary quite a bit between experiments?</p><p>6) For <xref ref-type="fig" rid="fig2">Figure 2A</xref>, the right panel, NOG/SB inhibition in endoderm cultures does not seem to have led to induction of PAX8, as was concluded in Results.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.05098.029</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p><italic>In this study, the authors describe a systematically delineated 3D protocol to generate human lung organoids from human pluripotent stem cells. HLOs possess organized proximal airway structures with apparently multiple differentiated epithelial cell types, as well as smooth muscle cells</italic>.</p><p><italic>There was enthusiasm for the overall concept and the potential of the system to be used to model lung differentiation, homeostasis and disease in vitro. This work should be of interest to the readership of</italic> eLife<italic>. However, there were concerns raised about the lack of in depth characterization of the different cell types generated and the lack of careful quantification of the extent of ordered differentiation in the system. For the paper to be reconsidered, we would ask you to address the various specific comments below, but to focus on careful characterization of the different lung cell types generated by extensive use of confocal imaging of co-staining with appropriate antibodies, such as FOXJ1, beta-tubulin, CC10, SCGB1A1, SCGB3A2, P63, Podoplanin, HOPX1, and more markers of SM compartment.</italic></p><p>We agree with the reviewers that HLOs were not adequately described in quantitative detail. To address these concerns, we have now added a significant amount of new imaging, morphometric analysis and bioinformatics data to help paint a clearer picture of the HLO. Specifically, we have conducted the following:</p><p>1) Quantitated the % of HLOs that possess proximal airway-like structures (<xref ref-type="fig" rid="fig7">Figure 7A</xref>).</p><p>2) Quantitated the % of area in HLOs that are comprised or either proximal airway-like structures or distal airway-like structures (<xref ref-type="fig" rid="fig7">Figure 7B</xref>).</p><p>3) Quantitated the % of cells in HLOs that express NKX2.1, P63, FOXJ1, SPC, PDPN (<xref ref-type="fig" rid="fig7">Figure 7C-G</xref>).</p><p>4) Serial slices from confocal Z-stack images co-labeled with: i) ECAD/SOX9/SOX2; ii) P63/ECAD; and iii) P63/aSMA (<xref ref-type="fig" rid="fig3s6">Figure 3–figure supplement 6</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4–figure supplement 1</xref>).</p><p>5) Importantly, through our analysis, we observed that staining for some cell types, including Club cells, was very rare. Coupled with our observation that some cells were reminiscent of fetal airway progenitors (SOX9+/SFTPC+), this led us to hypothesize that the HLOs were fetal in nature. In order to determine if was indeed the case, we used RNA sequencing to compare HLOs to human fetal lungs and human adult lungs. This transcriptome-wide comparison strongly suggests that HLOs are very similar to fetal lung (<xref ref-type="fig" rid="fig8">Figure 8</xref>).</p><p><italic>It would also be important to provide more evidence that the organoids really regenerate at least partially the ordered branching seen in the lung- such that you could define a bronchioalveolar duct junction (BADJ) with the proper smooth muscle configuration</italic>.</p><p>Our new analysis suggests there is some organoid-to-organoid variation in terms of general structure/architecture. That is, greater than 80% of HLOs examined (n=48) had definitive proximal airway-like structures (<xref ref-type="fig" rid="fig7">Figure 7A</xref>), and that these proximal airway-like structures accounted for ∼20% of the organoid cross-sectional area. The remaining 80% of the HLO was comprised of distal airway-like structures, where SFTPC+ and HOPX+ cells were found. Importantly, we also show that these distal-like airway structures had abundant myofibroblasts, fibroblasts and smooth muscle cells (<xref ref-type="fig" rid="fig5">Figure 5</xref>), but not cartilage. However, we did not find evidence that HLOs undergo branching morphogenesis or form proper BADJ structures.</p><p>Much like HLOs, intestinal organoids (Spence et al., Nature 2011) are poorly organized in vitro and only obtain higher order structure when transplanted in vivo (Watson et al., Nature Medicine, 2014). This higher order structure may result from a more complex growth environment that may include new cellular inputs (vasculature, innervation), circulating metabolites, or by changes in the mechanical forces placed on tissue transplanted under a kidney capsule. However, at this time, all of these possibilities are pure speculation. We have full intentions of determining if transplanting HLOs into the in vivo environment will enhance structural organization, however, due to the need to establish surgical procedures in my lab, and the time it may take for HLOs to structurally mature in vivo (&gt;12 weeks), we feel that these experiments are outside the scope of the current work.</p><p>Therefore, in order to be as forthright as possible, we have added into our Discussion section that we do not find evidence of a BADJ or branching morphogenesis.</p><p><italic>Further definition of the cell types arising from the mesenchyme would also be useful. Are there any cartilage cells or other types of cells such as lipofibroblasts, myofibroblasts, etc</italic>.</p><p>We have now included a new figure showing immunofluorescent staining to examine the mesenchymal compartment of HLOs (<xref ref-type="fig" rid="fig5">Figure 5</xref>). We also stained HLOs with Safranin O, which identifies cartilage, and find that HLOs do not possess cartilage, whereas iPSC-derived teratomas had abundant Safranin O-positive cartilage staining.</p><p><italic>In addition, some quantification of the proportions of different cell types produced and comparison with other published lung differentiation protocols is required</italic>.</p><p>We agree that comparing our results to those of others is important. It is interesting that re-reviewing the literature led us to the realization that some groups making very important contributions to the field did not conduct such a detailed analysis of the proportion of cell types. In this light, we have included a section in the Discussion comparing our analysis to those of others whenever data was available.</p><p><italic>We recognize that functional assessment of the cell types produced is difficult but use of EM identify lamellar bodies in type 2 cells would help</italic>.</p><p>We have now conducted TEM and find clear evidence of lamellar bodies that are both within cells, and that have been secreted into the extracellular space.</p><p><italic>Specific comments:</italic></p><p>Reviewer #1:</p><p><xref ref-type="fig" rid="fig1"><italic>Figure 1</italic></xref><italic>: Foregut endoderm should be characterized by double positive for FOXA2+SOX2+. SOX2 single expression is not enough for anterior endoderm identification</italic>.</p><p>We now provide low-magnification (wide field of view) co-staining of FOXA2/SOX2 for Endoderm, Foregut Endoderm, and Foregut endoderm treated with SAG or SAG+SU5402. This staining is now included in <xref ref-type="fig" rid="fig2s1">Figure 2–figure supplement 1</xref>.</p><p><xref ref-type="fig" rid="fig2"><italic>Figure 2</italic></xref><italic>: especially</italic> <xref ref-type="fig" rid="fig2s1"><italic>Figure 2</italic>–<italic>figure supplement1</italic></xref><italic>. In order to ensure NKX2.1+ are endoderm derived lung progenitors, co-staining with a battery of markers including FOXA2, SOX9, ID2, FOXP2 etc. are needed for comprehensive characterization</italic>.</p><p>We now include NKX2.1/FOXA2 and NKX2.1/SOX9 co-staining for each condition in <xref ref-type="fig" rid="fig1s1">Figure 1–figure supplement 1</xref>.</p><p><xref ref-type="fig" rid="fig3"><italic>Figure 3</italic></xref><italic>: In the text, the authors claimed that most spheres co-expressed FOXA2, SOX2, and NKX2.1 protein. However, only single marker staining was shown. Double and triple staining is highly recommended</italic>.</p><p>We have now conducted this analysis and include the data in <xref ref-type="fig" rid="fig3s3">Figure 3–figure supplement 3</xref>.</p><p><xref ref-type="fig" rid="fig3"><italic>Figure 3E</italic></xref><italic>: the authors claimed that their lung organoids contains bipotent alveolar progenitor markers including NMYC, ID2, NKX2.1, SPC, and HOPX based on their q-PCR analysis. Those differentiated markers need to validated with double or triple co-staining</italic>.</p><p>We apologize for the unclear text. The point we were trying to get across is that high NMYC and ID2 mRNA levels are consistent with an early lung state. We have done co-staining for SFTPC/SOX9 and HOPX/SOX9. Double-positive cells also suggest these may be less differentiated. We have tried to clarify the text around this problem.</p><p>In addition, rather than using a few molecular markers and co-stained cells to speculate on the “maturation state” of HLOs, we now directly address this using RNA sequencing. By comparing whole transcriptome signatures of HLOs to fetal lung, adult lung, ES cells and definitive endoderm. This data is now presented in <xref ref-type="fig" rid="fig8">Figure 8</xref>. Based on global RNA expression levels, this analysis strongly suggests that HLOs are more similar to fetal/immature lung.</p><p><italic>In supplemental figures for</italic> <xref ref-type="fig" rid="fig3"><italic>Figure 3</italic></xref><italic>, the authors indicated that the majority of cells lose epithelial identity and become vimentin positive mesenchymal cells over time. It is also still possible that mesenchyme overgrew epithelium</italic>.</p><p>This point is correct and well taken. We have now revised the text to encompass this possibility.</p><p><xref ref-type="fig" rid="fig4"><italic>Figure 4</italic></xref><italic>: Most differentiation marker staining is of poor quality and hard to interpret. For example, acetylated tubulin staining for ciliated cell is within the cell, rather than extend outside of the cell like cilia (</italic><xref ref-type="fig" rid="fig4"><italic>Figure 4C</italic></xref><italic>)</italic>.</p><p>Indeed, the reviewer is correct about the intracellular AcTUB staining, however, we do not believe this is due to poor quality of staining. Rather, as we state in the text, we believe that these FOXJ1+ cells are not forming proper multi-ciliated structures and may reflect the immature cellular state of HLOs. Our results from growing HLOs on acellular human lung matrix support this idea, since growth on the human matrix promotes proper multicilliated structures.</p><p><italic>CCSP is dot-like (</italic><xref ref-type="fig" rid="fig4"><italic>Figure 4C</italic></xref><italic>)</italic>.</p><p>We find these CCSP+ cells only very rarely, and again, believe their sparcity and staining pattern are reflective of a less differentiated tissue.</p><p><italic>P63 expression is a general epithelial stem cell markers, therefore co-staining of P63 with NKX2.1, FOXA2 and SOX2 are needed to ensure they are airway epithelial stem cells (</italic><xref ref-type="fig" rid="fig4"><italic>Figure 4B</italic></xref><italic>)</italic>.</p><p>Point well taken. Unfortunately, due to antibody specificity, we were unable to conduct NKX2.1/P63 co-staining. Instead, we have conducted staining on serial sections to show that cells in adjacent sections are staining positive for both markers. Additionally, we show that P63+ cells also express SOX2. This data is presented in <xref ref-type="fig" rid="fig4s2">Figure 4–figure supplement 2</xref>.</p><p><xref ref-type="fig" rid="fig5"><italic>Figure 5</italic></xref><italic>: Again, all markers need to be co-stained with NKX2.1 to ensure the lung progenitor identity. In both</italic> <xref ref-type="fig" rid="fig4"><italic>Figure 4</italic></xref> <italic>and</italic> <xref ref-type="fig" rid="fig5"><italic>Figure 5</italic></xref><italic>, the authors need to provide quantitative data concerning the efficiency of airway and alveolar differentiation in their organoids</italic>.</p><p>We have now conducted co-staining and quantitation of the HLO. This data is presented in <xref ref-type="fig" rid="fig6">Figure 6</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6–figure supplement 1</xref> and in <xref ref-type="fig" rid="fig7">Figure 7</xref>. Again, due to antibody specificity limitations, some of this analysis was conducted on serial sections.</p><p>Reviewer #2:</p><p><italic>1) HLOs have the ability to generate mature airway cells, but predominantly possess a bipotent alveolar progenitors. Does this protocol favors to proximal lung development? Does the length of time in 3D culture alter the ratio of proximal versus distal</italic>?</p><p>Given our new quantitative analysis of the HLOs and RNAseq comparisons to adult and fetal lung, we do not believe that our methods favor proximal lung development. Our current thought is that the relatively low abundance of mature alveolar cells may be reflective of the immature/fetal nature of the HLO. Moreover, it is possible that our culture conditions, which utilize high levels of FGF10, may promote this less differentiated cellular state, and our data suggests that distal differentiation may require prolonged time in culture, since SFTPC begins to increase after ∼65 days in culture, and continues to increase at 110 days in culture, the latest time we have examined.</p><p>We believe that the best experiment to test these possibilities is to transplant the HLOs into a recipient host (NSG mouse), and determine if they show enhanced cellular differentiation. As mentioned above, we are currently working toward establishing the techniques required to conduct these experiments in the Spence lab, but are unable to do so at this time.</p><p><italic>2) Increase in HH signaling leads to an increase in NKX2-1 expression in culture. Since HH signaling is received by mesenchymal cells, what is mediating its effect on NKX2-1</italic>?</p><p>This is a very good question, and one that does not have a definitive answer at this time. It is clear from our experiment in <xref ref-type="fig" rid="fig2">Figure 2C</xref> that HH signaling is required for NKX2.1 expression in NOG/SB treated foregut endoderm. When we inhibit HH with a small molecule, Sant-2, NKX2.1 expression is reduced. However, we still do not understand the mechanism by which this happens. One strong possibility is that HH signaling enhances mesenchymal proliferation and/or survival in HLOs, thus increasing important reciprocal signaling events between the two populations. Indeed, immunostaining of NOG/SB/F/CH spheroids (<xref ref-type="fig" rid="fig1s3">Figure 1–figure supplement 3</xref>) and NOG/SB/F/CH/SAG spheroids (<xref ref-type="fig" rid="fig3s5">Figure 3–figure supplement 5</xref>) for the mesenchymal marker Vimentin (VIM) revealed that there may be more mesenchymal cells present in SAG treated spheroids. However, differences between these groups were not significant by QRTPCR (data not shown).</p><p><italic>3) Combined inhibition of endogenous FGF signaling with SU and activation of HH with SAG caused an additional increase in NKX2-1 expression (21 fold vs. 6.5 fold with SAG only). However, treating foregut cultures with SU along did not alter NKX2.1 expression. What is the explanation for the increase in NKX2-1 expression with the SU and HH combination</italic>?</p><p>We believe that our data supports a paradigm where both factors in combination (SAG+SU) support robust expression of NKX2.1 in more cells when compared with addition of SAG alone (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1–figure supplement 1</xref>). In this scenario, SAG alone results in robust “patches” of NKX2.1+ cells in the monolayer whereas SAG+SU promotes robust protein expression of NKX2.1 in majority of cells within a field.</p><p>This may be due to the fact that with SAG alone, cells still receive endogenous FGF signals, and have more lineage choices to make, whereas removing FGF narrows the number of decisions a cell has such that more commit to an NKX2.1+ lineage.</p><p><italic>4) What effect does HH has on SMC differentiation in culture</italic>?</p><p>This is an interesting question given previously described roles for HH on smooth muscle differentiation. We conducted several experiments in an attempt to address this reviewer question, and unfortunately, we did not see definitive changes in smooth muscle differentiation when we manipulated HH signaling (data not shown). We believe that this is likely due to experimental design. For example, it is possible we did not use high enough doses or long enough exposures to see an effect. These experiments are still ongoing, however, at this time we only have negative data to report and have chosen not to comment in the revised manuscript.</p><p><italic>5) Comparing experiments in</italic> <xref ref-type="fig" rid="fig2"><italic>Figure 2C</italic></xref> <italic>versus 2D, it seems that NKX2-1 and PAX8 induction in these two experiments are quite different. Does the efficiency vary quite a bit between experiments</italic>?</p><p>We believe that this variability arises from our “endoderm control” group, in which we add ActivinA for four days, followed by only basal media with no growth factors for an additional 12 days. In this setting, cells that have been induced to become endoderm but given no additional cues begin to undergo stochastic differentiation into multiple lineages, as we have previously shown (Spence et al., 2011). Thus, in these types of experiments, while the trends in gene expression are usually reproducible, the level of the changes vary somewhat from experiment to experiment, as the reviewer points out in 2C vs. 2D.</p><p><italic>6) For</italic> <xref ref-type="fig" rid="fig2"><italic>Figure 2A</italic></xref><italic>, the right panel, NOG/SB inhibition in endoderm cultures does not seem to have led to induction of PAX8, as was concluded in Results</italic>.</p><p>This reviewer brings up a good point, and we have tried to clarify the text surrounding this result, and we offer the following explanation; For this experiment, all conditions were analyzed after the same amount of time in culture. For the endoderm control, endoderm was induced for 4 days, and then placed in basal culture media for the duration of the experiment (12 days).</p><p>Similarly, the Foregut condition received ActivinA for four days, followed by four days of NOG/SB, and followed by 8 days in basal media. And so on. The likely reason PAX8 is not highly expressed in this experiment is that its expression is not maintained over time in the absence of any growth factors. This is supported by <xref ref-type="fig" rid="fig3s3">Figure 3–figure supplement 3</xref>, where we generated foregut endoderm (NOG/SB) and then treated it with FGF2 for 8 days, and observed many PAX8+ cells within the monolayer.</p></body></sub-article></article>